##gff-version 3								
##gvf-version 1.10								
##species NCBI_Taxonomy_URI=http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=2697049								
#seqid	#source	#type	#start	#end	#score	#strand	#phase	#attributes
NC_045512.2	.	snp	174	174	.	+	.	ID=ID_0;Name=g.G-92T;ps_filter=;Variant_seq=T;mutation_type=;vcf_gene=ORF1ab;aa_name=;mat_pep_acc=;ro=65;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.G-92T;ps_exc=;chrom_region=intergenic;protein=n/a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	210	210	.	+	.	ID=ID_1;Name=g.G-56T;ps_filter=;Variant_seq=T;mutation_type=;vcf_gene=ORF1ab;aa_name=;mat_pep_acc=;ro=0;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.G-56T;ps_exc=;chrom_region=intergenic;protein=n/a;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	241	241	.	+	.	ID=ID_2;Name=g.C-25T;ps_filter=;Variant_seq=T;mutation_type=;vcf_gene=ORF1ab;aa_name=;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.C-25T;ps_exc=;chrom_region=intergenic;protein=n/a;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	347	347	.	+	.	ID=ID_3;Name=V28I;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.V28I;mat_pep_acc=;ro=62;Reference_seq=G;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=7;nt_name=g.G82A;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.10144927536231885;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	370	370	.	+	.	ID=ID_4;Name=V35V;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.V35V;mat_pep_acc=;ro=0;Reference_seq=G;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=69;nt_name=g.G105T;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	442	442	.	+	.	ID=ID_5;Name=G59G;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.G59G;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=1;nt_name=g.C177T;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	507	507	.	+	.	ID=ID_6;Name=M85del;ps_filter=;Variant_seq=ATGGTCATGTTGTT;mutation_type=;vcf_gene=ORF1ab;aa_name=p.M85del;mat_pep_acc=;ro=65;Reference_seq=ATGGTCATGTTATGGTT;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=2;nt_name=g.253_255delATG;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=immunosuppression variant emergence;source=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640888/;citation=Avanzato et al. (2020);comb_mutation=;function_description=Emergent as 22% variant by day 70 post-infection of female immunocompromised  individual with chronic lymphocytic leukemia and acquired hypogammaglobulinemia.  Variant became 100% in day 70 culture. Variant disappeared after convalescent plasma treatment (day 71) in subsequent patient sample sequencing.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	507	507	.	+	.	ID=ID_6;Name=M85del;ps_filter=;Variant_seq=ATGGTCATGTTGTT;mutation_type=;vcf_gene=ORF1ab;aa_name=p.M85del;mat_pep_acc=;ro=65;Reference_seq=ATGGTCATGTTATGGTT;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=2;nt_name=g.253_255delATG;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=IFN activity;source=https://doi.org/10.1016/j.chom.2021.01.015;citation=Lin et al. (2021);comb_mutation=;function_description=Deletions in the genomic nucleotide 500-523 range are shown in vitro culture to downregulated  interferon A1/2 & B1 expression, and are associated with lower clinical severity of disease (Jan-Mar 2020 in China). variations of deletion in this region are found in separate lineages throughout the globe. This specific deletion (genomic 500-523) was tested in vitro for IFN response.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	507	507	.	+	.	ID=ID_6;Name=M85del;ps_filter=;Variant_seq=ATGGTCATGTTGTT;mutation_type=;vcf_gene=ORF1ab;aa_name=p.M85del;mat_pep_acc=;ro=65;Reference_seq=ATGGTCATGTTATGGTT;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=2;nt_name=g.253_255delATG;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=IFN activity;source=https://doi.org/10.1016/j.chom.2021.01.015;citation=Lin et al. (2021);comb_mutation=;function_description=Deletions in the genomic nucleotide 500-523 range are shown in vitro culture to downregulated  interferon A1/2 & B1 expression, and are associated with lower clinical severity of disease (Jan-Mar 2020 in China). variations of deletion in this region are found in separate lineages throughout the globe. This specific deletion (genomic 509-523) was tested in vitro for IFN response.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	507	507	.	+	.	ID=ID_6;Name=M85del;ps_filter=;Variant_seq=ATGGTCATGTTGTT;mutation_type=;vcf_gene=ORF1ab;aa_name=p.M85del;mat_pep_acc=;ro=65;Reference_seq=ATGGTCATGTTATGGTT;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=2;nt_name=g.253_255delATG;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=IFN activity;source=https://doi.org/10.1016/j.chom.2021.01.015;citation=Lin et al. (2021);comb_mutation=;function_description=Deletions in the genomic nucleotide 500-523 range are shown in vitro culture to downregulated  interferon A1/2 & B1 expression, and are associated with lower clinical severity of disease (Jan-Mar 2020 in China). variations of deletion in this region are found in separate lineages throughout the globe. This specific deletion (genomic 509-517) was tested in vitro for IFN response.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	507	507	.	+	.	ID=ID_7;Name=G82_V86del;ps_filter=;Variant_seq=AT;mutation_type=;vcf_gene=ORF1ab;aa_name=p.G82_V86del;mat_pep_acc=;ro=65;Reference_seq=ATGGTCATGTTATGGTT;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=1;nt_name=g.245_259delGTCATGTTATGGTTG;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	507	507	.	+	.	ID=ID_6;Name=M85del;ps_filter=;Variant_seq=ATGGTCATGTGGTT;mutation_type=;vcf_gene=ORF1ab;aa_name=p.M85del;mat_pep_acc=;ro=65;Reference_seq=ATGGTCATGTTATGGTT;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=1;nt_name=g.252_254delTAT;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=immunosuppression variant emergence;source=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640888/;citation=Avanzato et al. (2020);comb_mutation=;function_description=Emergent as 22% variant by day 70 post-infection of female immunocompromised  individual with chronic lymphocytic leukemia and acquired hypogammaglobulinemia.  Variant became 100% in day 70 culture. Variant disappeared after convalescent plasma treatment (day 71) in subsequent patient sample sequencing.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	507	507	.	+	.	ID=ID_6;Name=M85del;ps_filter=;Variant_seq=ATGGTCATGTGGTT;mutation_type=;vcf_gene=ORF1ab;aa_name=p.M85del;mat_pep_acc=;ro=65;Reference_seq=ATGGTCATGTTATGGTT;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=1;nt_name=g.252_254delTAT;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=IFN activity;source=https://doi.org/10.1016/j.chom.2021.01.015;citation=Lin et al. (2021);comb_mutation=;function_description=Deletions in the genomic nucleotide 500-523 range are shown in vitro culture to downregulated  interferon A1/2 & B1 expression, and are associated with lower clinical severity of disease (Jan-Mar 2020 in China). variations of deletion in this region are found in separate lineages throughout the globe. This specific deletion (genomic 500-523) was tested in vitro for IFN response.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	507	507	.	+	.	ID=ID_6;Name=M85del;ps_filter=;Variant_seq=ATGGTCATGTGGTT;mutation_type=;vcf_gene=ORF1ab;aa_name=p.M85del;mat_pep_acc=;ro=65;Reference_seq=ATGGTCATGTTATGGTT;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=1;nt_name=g.252_254delTAT;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=IFN activity;source=https://doi.org/10.1016/j.chom.2021.01.015;citation=Lin et al. (2021);comb_mutation=;function_description=Deletions in the genomic nucleotide 500-523 range are shown in vitro culture to downregulated  interferon A1/2 & B1 expression, and are associated with lower clinical severity of disease (Jan-Mar 2020 in China). variations of deletion in this region are found in separate lineages throughout the globe. This specific deletion (genomic 509-523) was tested in vitro for IFN response.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	507	507	.	+	.	ID=ID_6;Name=M85del;ps_filter=;Variant_seq=ATGGTCATGTGGTT;mutation_type=;vcf_gene=ORF1ab;aa_name=p.M85del;mat_pep_acc=;ro=65;Reference_seq=ATGGTCATGTTATGGTT;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=1;nt_name=g.252_254delTAT;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=IFN activity;source=https://doi.org/10.1016/j.chom.2021.01.015;citation=Lin et al. (2021);comb_mutation=;function_description=Deletions in the genomic nucleotide 500-523 range are shown in vitro culture to downregulated  interferon A1/2 & B1 expression, and are associated with lower clinical severity of disease (Jan-Mar 2020 in China). variations of deletion in this region are found in separate lineages throughout the globe. This specific deletion (genomic 509-517) was tested in vitro for IFN response.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	598	598	.	+	.	ID=ID_8;Name=V111V;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.V111V;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=1;nt_name=g.G333T;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	683	683	.	+	.	ID=ID_9;Name=L140L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.L140L;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=1;nt_name=g.C418T;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	685	685	.	+	.	ID=ID_10;Name=K141_F143del;ps_filter=;Variant_seq=AG;mutation_type=;vcf_gene=ORF1ab;aa_name=p.K141_F143del;mat_pep_acc=;ro=68;Reference_seq=AAAGTCATTTG;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=1;nt_name=g.421_429delAAGTCATTT;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	745	745	.	+	.	ID=ID_11;Name=N160N;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.N160N;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=69;nt_name=g.C480T;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	761	761	.	+	.	ID=ID_12;Name=S166G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.S166G;mat_pep_acc=;ro=67;Reference_seq=A;mat_pep_id=leader protein;dp=69;mat_pep_desc=nsp1, produced by both pp1a and pp1ab;ao=2;nt_name=g.A496G;ps_exc=;chrom_region=ORF1a;protein=NSP1;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	823	823	.	+	.	ID=ID_13;Name=V186V;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.V186V;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=69;nt_name=g.C558T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	884	884	.	+	.	ID=ID_14;Name=R207G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.R207G;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=3;nt_name=g.C619G;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	1124	1124	.	+	.	ID=ID_15;Name=R287R;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.R287R;mat_pep_acc=;ro=65;Reference_seq=A;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=4;nt_name=g.A859C;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	1150	1150	.	+	.	ID=ID_16;Name=G295G;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.G295G;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.C885T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	1350	1350	.	+	.	ID=ID_17;Name=Q362L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.Q362L;mat_pep_acc=;ro=67;Reference_seq=A;mat_pep_id=nsp2;dp=68;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.A1085T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014705882352941176;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	1392	1392	.	+	.	ID=ID_18;Name=S376L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.S376L;mat_pep_acc=;ro=67;Reference_seq=C;mat_pep_id=nsp2;dp=68;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.C1127T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014705882352941176;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	1634	1634	.	+	.	ID=ID_19;Name=E457K;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.E457K;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.G1369A;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	1657	1657	.	+	.	ID=ID_20;Name=V464V;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.V464V;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.T1392C;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	1719	1719	.	+	.	ID=ID_21;Name=S485I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.S485I;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.G1454T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	1758	1758	.	+	.	ID=ID_22;Name=A498V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A498V;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.C1493T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	1855	1855	.	+	.	ID=ID_23;Name=L530L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.L530L;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.G1590T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	1922	1922	.	+	.	ID=ID_24;Name=E553K;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.E553K;mat_pep_acc=;ro=64;Reference_seq=G;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=5;nt_name=g.G1657A;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.07246376811594203;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	2035	2035	.	+	.	ID=ID_25;Name=L590F;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.L590F;mat_pep_acc=;ro=62;Reference_seq=G;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=7;nt_name=g.G1770T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.10144927536231885;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	2081	2081	.	+	.	ID=ID_26;Name=V606F;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.V606F;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.G1816T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	2110	2110	.	+	.	ID=ID_27;Name=N615N;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.N615N;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.C1845T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	2113	2113	.	+	.	ID=ID_28;Name=I616I;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.I616I;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=3;nt_name=g.C1848T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	2447	2447	.	+	.	ID=ID_29;Name=G728C;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.G728C;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=2;nt_name=g.G2182T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	2647	2647	.	+	.	ID=ID_30;Name=K794K;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.K794K;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.A2382G;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	2695	2695	.	+	.	ID=ID_31;Name=N810N;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.N810N;mat_pep_acc=;ro=65;Reference_seq=C;mat_pep_id=nsp2;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=4;nt_name=g.C2430T;ps_exc=;chrom_region=ORF1a;protein=NSP2;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	2803	2803	.	+	.	ID=ID_32;Name=D846D;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.D846D;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=4;nt_name=g.T2538C;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	2978	2978	.	+	.	ID=ID_33;Name=Y905H;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.Y905H;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.T2713C;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	complex	3037	3037	.	+	.	ID=ID_34;Name=F924F;ps_filter=;Variant_seq=TTAT;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.F924F;mat_pep_acc=;ro=0;Reference_seq=CTAC;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C2772T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	3037	3037	.	+	.	ID=ID_35;Name=926;ps_filter=;Variant_seq=TTAC;mutation_type=;vcf_gene=ORF1ab;aa_name=p.926;mat_pep_acc=;ro=0;Reference_seq=CTAC;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=68;nt_name=g.CTAC2772_2775TTAT;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.9855072463768116;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	3341	3341	.	+	.	ID=ID_36;Name=N1026H;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.N1026H;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.A3076C;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	3393	3393	.	+	.	ID=ID_37;Name=A1043V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A1043V;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=3;nt_name=g.C3128T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	3403	3403	.	+	.	ID=ID_38;Name=V1046V;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.V1046V;mat_pep_acc=;ro=66;Reference_seq=G;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=3;nt_name=g.G3138T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	3514	3514	.	+	.	ID=ID_39;Name=M1083I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.M1083I;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.G3249T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	3634	3634	.	+	.	ID=ID_40;Name=N1123N;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.N1123N;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C3369T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	4181	4181	.	+	.	ID=ID_41;Name=A1306S;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A1306S;mat_pep_acc=;ro=0;Reference_seq=G;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=69;nt_name=g.G3916T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	4309	4309	.	+	.	ID=ID_42;Name=K1348N;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.K1348N;mat_pep_acc=;ro=65;Reference_seq=G;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=4;nt_name=g.G4044T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	4320	4320	.	+	.	ID=ID_43;Name=A1352V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A1352V;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C4055T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	4423	4423	.	+	.	ID=ID_44;Name=R1386R;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.R1386R;mat_pep_acc=;ro=63;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=6;nt_name=g.C4158T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.08695652173913043;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	4427	4427	.	+	.	ID=ID_45;Name=L1388L;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.L1388L;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.T4162C;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	4543	4543	.	+	.	ID=ID_46;Name=T1426T;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.T1426T;mat_pep_acc=;ro=65;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=4;nt_name=g.C4278T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	4788	4788	.	+	.	ID=ID_47;Name=A1508V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A1508V;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C4523T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	4898	4898	.	+	.	ID=ID_48;Name=H1545Y;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.H1545Y;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C4633T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	5015	5015	.	+	.	ID=ID_49;Name=V1584M;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.V1584M;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.G4750A;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	5301	5301	.	+	.	ID=ID_50;Name=A1679V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A1679V;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C5036T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	5365	5365	.	+	.	ID=ID_51;Name=Y1700Y;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.Y1700Y;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C5100T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	5583	5583	.	+	.	ID=ID_52;Name=T1773I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T1773I;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C5318T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	5849	5849	.	+	.	ID=ID_53;Name=P1862S;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.P1862S;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C5584T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	5850	5850	.	+	.	ID=ID_54;Name=P1862L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.P1862L;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C5585T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	6268	6268	.	+	.	ID=ID_55;Name=A2001A;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.A2001A;mat_pep_acc=;ro=67;Reference_seq=C;mat_pep_id=nsp3;dp=68;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C6003T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014705882352941176;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	6402	6402	.	+	.	ID=ID_56;Name=P2046L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.P2046L;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=69;nt_name=g.C6137T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	6449	6449	.	+	.	ID=ID_57;Name=L2062F;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.L2062F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C6184T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	6572	6572	.	+	.	ID=ID_58;Name=S2103P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.S2103P;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.T6307C;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	6693	6693	.	+	.	ID=ID_59;Name=K2143R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.K2143R;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.A6428G;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	6738	6738	.	+	.	ID=ID_60;Name=T2158I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T2158I;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C6473T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	6828	6828	.	+	.	ID=ID_61;Name=S2188F;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.S2188F;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=69;nt_name=g.C6563T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	6971	6971	.	+	.	ID=ID_62;Name=L2236L;ps_filter=caution;Variant_seq=C;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.L2236L;mat_pep_acc=;ro=66;Reference_seq=T;mat_pep_id=nsp3;dp=67;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.T6706C;ps_exc=neighbour_linked,single_src;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014925373134328358;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	7124	7124	.	+	.	ID=ID_63;Name=P2287S;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.P2287S;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=69;nt_name=g.C6859T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	7626	7626	.	+	.	ID=ID_64;Name=N2454S;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.N2454S;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.A7361G;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	7735	7735	.	+	.	ID=ID_65;Name=I2490I;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.I2490I;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.C7470T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	7857	7857	.	+	.	ID=ID_66;Name=N2531S;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.N2531S;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.A7592G;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	7869	7869	.	+	.	ID=ID_67;Name=S2535L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.S2535L;mat_pep_acc=;ro=63;Reference_seq=C;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=6;nt_name=g.C7604T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.08695652173913043;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	8171	8171	.	+	.	ID=ID_68;Name=A2636T;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A2636T;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=1;nt_name=g.G7906A;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	8179	8179	.	+	.	ID=ID_69;Name=R2638R;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.R2638R;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=nsp3;dp=69;mat_pep_desc=former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab;ao=2;nt_name=g.G7914T;ps_exc=;chrom_region=ORF1a;protein=NSP3;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	8770	8770	.	+	.	ID=ID_70;Name=D2835D;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.D2835D;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=1;nt_name=g.C8505T;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	8986	8986	.	+	.	ID=ID_71;Name=D2907D;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.D2907D;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=69;nt_name=g.C8721T;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	complex	9051	9051	.	+	.	ID=ID_72;Name=V2930L;ps_filter=;Variant_seq=TAT;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.V2930L;mat_pep_acc=;ro=0;Reference_seq=CAG;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=3;nt_name=g.G8788T;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	9051	9051	.	+	.	ID=ID_73;Name=PV2929LL;ps_filter=;Variant_seq=CAT;mutation_type=;vcf_gene=ORF1ab;aa_name=p.PV2929LL;mat_pep_acc=;ro=0;Reference_seq=CAG;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=66;nt_name=g.CAG8786_8788TAT;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.9565217391304348;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	9087	9087	.	+	.	ID=ID_74;Name=G2941D;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.G2941D;mat_pep_acc=;ro=65;Reference_seq=G;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=4;nt_name=g.G8822A;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	9197	9197	.	+	.	ID=ID_75;Name=T2978P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T2978P;mat_pep_acc=;ro=67;Reference_seq=A;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=2;nt_name=g.A8932C;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	9438	9438	.	+	.	ID=ID_76;Name=T3058I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T3058I;mat_pep_acc=;ro=67;Reference_seq=C;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=2;nt_name=g.C9173T;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	9559	9559	.	+	.	ID=ID_77;Name=Y3098Y;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.Y3098Y;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=3;nt_name=g.C9294T;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	9652	9652	.	+	.	ID=ID_78;Name=M3129I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.M3129I;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=1;nt_name=g.G9387T;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	9700	9700	.	+	.	ID=ID_79;Name=I3145I;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.I3145I;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=3;nt_name=g.C9435T;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	10029	10029	.	+	.	ID=ID_80;Name=T3255I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T3255I;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=69;nt_name=g.C9764T;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	10034	10034	.	+	.	ID=ID_81;Name=I3257V;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.I3257V;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=nsp4;dp=69;mat_pep_desc=nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab;ao=1;nt_name=g.A9769G;ps_exc=;chrom_region=ORF1a;protein=NSP4;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	10078	10078	.	+	.	ID=ID_82;Name=F3271F;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.F3271F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=3C-like proteinase;dp=69;mat_pep_desc=nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab;ao=1;nt_name=g.C9813T;ps_exc=;chrom_region=ORF1a;protein=NSP5;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	10287	10287	.	+	.	ID=ID_83;Name=I3341S;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.I3341S;mat_pep_acc=;ro=66;Reference_seq=T;mat_pep_id=3C-like proteinase;dp=69;mat_pep_desc=nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab;ao=3;nt_name=g.T10022G;ps_exc=;chrom_region=ORF1a;protein=NSP5;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	10312	10312	.	+	.	ID=ID_84;Name=V3349V;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.V3349V;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=3C-like proteinase;dp=69;mat_pep_desc=nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab;ao=1;nt_name=g.A10047G;ps_exc=;chrom_region=ORF1a;protein=NSP5;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	10519	10519	.	+	.	ID=ID_85;Name=D3418D;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.D3418D;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=3C-like proteinase;dp=69;mat_pep_desc=nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab;ao=1;nt_name=g.C10254T;ps_exc=;chrom_region=ORF1a;protein=NSP5;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	10733	10733	.	+	.	ID=ID_86;Name=L3490F;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.L3490F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=3C-like proteinase;dp=69;mat_pep_desc=nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab;ao=1;nt_name=g.C10468T;ps_exc=;chrom_region=ORF1a;protein=NSP5;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	10908	10908	.	+	.	ID=ID_87;Name=A3548V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A3548V;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=3C-like proteinase;dp=69;mat_pep_desc=nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab;ao=1;nt_name=g.C10643T;ps_exc=;chrom_region=ORF1a;protein=NSP5;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	11042	11042	.	+	.	ID=ID_88;Name=V3593F;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.V3593F;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp6;dp=69;mat_pep_desc=nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab;ao=1;nt_name=g.G10777T;ps_exc=;chrom_region=ORF1a;protein=NSP6;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	complex	11199	11199	.	+	.	ID=ID_89;Name=T3646A;ps_filter=;Variant_seq=TCG;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T3646A;mat_pep_acc=;ro=0;Reference_seq=CCA;mat_pep_id=nsp6;dp=69;mat_pep_desc=nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab;ao=1;nt_name=g.A10936G;ps_exc=;chrom_region=ORF1a;protein=NSP6;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	11199	11199	.	+	.	ID=ID_90;Name=AT3645VA;ps_filter=;Variant_seq=CCG;mutation_type=;vcf_gene=ORF1ab;aa_name=p.AT3645VA;mat_pep_acc=;ro=0;Reference_seq=CCA;mat_pep_id=nsp6;dp=69;mat_pep_desc=nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab;ao=68;nt_name=g.CCA10934_10936TCG;ps_exc=;chrom_region=ORF1a;protein=NSP6;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.9855072463768116;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	11332	11332	.	+	.	ID=ID_91;Name=V3689V;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.V3689V;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=nsp6;dp=68;mat_pep_desc=nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab;ao=68;nt_name=g.A11067G;ps_exc=;chrom_region=ORF1a;protein=NSP6;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	11417	11417	.	+	.	ID=ID_92;Name=V3718F;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.V3718F;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp6;dp=69;mat_pep_desc=nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab;ao=1;nt_name=g.G11152T;ps_exc=;chrom_region=ORF1a;protein=NSP6;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	11854	11854	.	+	.	ID=ID_93;Name=S3863S;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.S3863S;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=nsp7;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.A11589G;ps_exc=;chrom_region=ORF1a;protein=NSP7;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	11983	11983	.	+	.	ID=ID_94;Name=E3906E;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.E3906E;mat_pep_acc=;ro=66;Reference_seq=A;mat_pep_id=nsp7;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=3;nt_name=g.A11718G;ps_exc=;chrom_region=ORF1a;protein=NSP7;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	12163	12163	.	+	.	ID=ID_95;Name=Q3966H;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.Q3966H;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp8;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.G11898T;ps_exc=;chrom_region=ORF1a;protein=NSP8;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	12514	12514	.	+	.	ID=ID_96;Name=T4083T;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.T4083T;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp8;dp=69;mat_pep_desc=produced by both pp1a and pp1ab;ao=1;nt_name=g.G12249T;ps_exc=;chrom_region=ORF1a;protein=NSP8;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	12890	12890	.	+	.	ID=ID_97;Name=L4209L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.L4209L;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=nsp9;dp=69;mat_pep_desc=ssRNA-binding protein, produced by both pp1a and pp1ab;ao=3;nt_name=g.C12625T;ps_exc=;chrom_region=ORF1a;protein=NSP9;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	13011	13011	.	+	.	ID=ID_98;Name=T4249I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T4249I;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp9;dp=69;mat_pep_desc=ssRNA-binding protein, produced by both pp1a and pp1ab;ao=1;nt_name=g.C12746T;ps_exc=;chrom_region=ORF1a;protein=NSP9;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	13378	13378	.	+	.	ID=ID_99;Name=T4371T;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.T4371T;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=nsp10;dp=69;mat_pep_desc=nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab;ao=1;nt_name=g.C13113T;ps_exc=;chrom_region=ORF1a;protein=NSP10;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	13438	13438	.	+	.	ID=ID_100;Name=L4391L;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.L4391L;mat_pep_acc=;ro=66;Reference_seq=T;mat_pep_id=nsp10;dp=69;mat_pep_desc=nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab;ao=3;nt_name=g.T13173G;ps_exc=;chrom_region=ORF1a;protein=NSP10;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	13441	13441	.	+	.	ID=ID_101;Name=Q4392Q;ps_filter=;Variant_seq=A;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.Q4392Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=nsp10;dp=69;mat_pep_desc=nsp10_CysHis, formerly known as growth-factor-like protein (GFL), produced by both pp1a and pp1ab;ao=1;nt_name=g.G13176A;ps_exc=;chrom_region=ORF1a;protein=NSP10;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	13611	13611	.	+	.	ID=ID_102;Name=Q4449H;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.Q4449H;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=1;nt_name=g.A13347C;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	13615	13615	.	+	.	ID=ID_103;Name=K4451E;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.K4451E;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=1;nt_name=g.A13351G;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	13630	13630	.	+	.	ID=ID_104;Name=N4456D;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.N4456D;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=1;nt_name=g.A13366G;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	13907	13907	.	+	.	ID=ID_105;Name=Y4548C;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.Y4548C;mat_pep_acc=;ro=61;Reference_seq=A;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=8;nt_name=g.A13643G;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.11594202898550725;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	14220	14220	.	+	.	ID=ID_106;Name=D4652D;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.D4652D;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=1;nt_name=g.C13956T;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	14408	14408	.	+	.	ID=ID_107;Name=P4715L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.P4715L;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=69;nt_name=g.C14144T;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	14575	14575	.	+	.	ID=ID_108;Name=A4771S;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A4771S;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=1;nt_name=g.G14311T;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	14580	14580	.	+	.	ID=ID_109;Name=M4772I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.M4772I;mat_pep_acc=;ro=64;Reference_seq=G;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=5;nt_name=g.G14316T;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.07246376811594203;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	14932	14932	.	+	.	ID=ID_110;Name=L4890L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.L4890L;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=1;nt_name=g.C14668T;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	15372	15372	.	+	.	ID=ID_111;Name=T5036T;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.T5036T;mat_pep_acc=;ro=64;Reference_seq=G;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=5;nt_name=g.G15108T;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.07246376811594203;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	15417	15417	.	+	.	ID=ID_112;Name=C5051C;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.C5051C;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=1;nt_name=g.T15153C;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	15451	15451	.	+	.	ID=ID_113;Name=G5063S;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.G5063S;mat_pep_acc=;ro=0;Reference_seq=G;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=69;nt_name=g.G15187A;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	15728	15728	.	+	.	ID=ID_114;Name=V5155A;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.V5155A;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=1;nt_name=g.T15464C;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	15907	15907	.	+	.	ID=ID_115;Name=G5215C;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.G5215C;mat_pep_acc=;ro=66;Reference_seq=G;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=3;nt_name=g.G15643T;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	16178	16178	.	+	.	ID=ID_116;Name=S5305L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.S5305L;mat_pep_acc=;ro=61;Reference_seq=C;mat_pep_id=RNA-dependent RNA polymerase;dp=69;mat_pep_desc=nsp12, NiRAN and RdRp, produced by pp1ab only;ao=8;nt_name=g.C15914T;ps_exc=;chrom_region=ORF1b;protein=NSP12;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.11594202898550725;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	16466	16466	.	+	.	ID=ID_117;Name=P5401L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.P5401L;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=helicase;dp=69;mat_pep_desc=nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only;ao=69;nt_name=g.C16202T;ps_exc=;chrom_region=ORF1b;protein=NSP13;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	16622	16622	.	+	.	ID=ID_118;Name=R5453K;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.R5453K;mat_pep_acc=;ro=65;Reference_seq=G;mat_pep_id=helicase;dp=69;mat_pep_desc=nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only;ao=4;nt_name=g.G16358A;ps_exc=;chrom_region=ORF1b;protein=NSP13;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	16853	16853	.	+	.	ID=ID_119;Name=G5530V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.G5530V;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=helicase;dp=69;mat_pep_desc=nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only;ao=1;nt_name=g.G16589T;ps_exc=;chrom_region=ORF1b;protein=NSP13;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	16887	16887	.	+	.	ID=ID_120;Name=Y5541Y;ps_filter=mask;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.Y5541Y;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=helicase;dp=69;mat_pep_desc=nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only;ao=1;nt_name=g.C16623T;ps_exc=highly_homoplasic;chrom_region=ORF1b;protein=NSP13;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	17125	17125	.	+	.	ID=ID_121;Name=L5621I;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.L5621I;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=helicase;dp=69;mat_pep_desc=nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only;ao=1;nt_name=g.C16861A;ps_exc=;chrom_region=ORF1b;protein=NSP13;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	17339	17339	.	+	.	ID=ID_122;Name=A5692V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A5692V;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=helicase;dp=69;mat_pep_desc=nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only;ao=3;nt_name=g.C17075T;ps_exc=;chrom_region=ORF1b;protein=NSP13;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	17427	17427	.	+	.	ID=ID_123;Name=V5721V;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.V5721V;mat_pep_acc=;ro=65;Reference_seq=G;mat_pep_id=helicase;dp=69;mat_pep_desc=nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only;ao=4;nt_name=g.G17163T;ps_exc=;chrom_region=ORF1b;protein=NSP13;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	17875	17875	.	+	.	ID=ID_124;Name=T5871A;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T5871A;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=helicase;dp=69;mat_pep_desc=nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only;ao=1;nt_name=g.A17611G;ps_exc=;chrom_region=ORF1b;protein=NSP13;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	18032	18032	.	+	.	ID=ID_125;Name=T5923I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T5923I;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=helicase;dp=69;mat_pep_desc=nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only;ao=1;nt_name=g.C17768T;ps_exc=;chrom_region=ORF1b;protein=NSP13;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	18131	18131	.	+	.	ID=ID_126;Name=T5956I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T5956I;mat_pep_acc=;ro=65;Reference_seq=C;mat_pep_id=3'-to-5' exonuclease;dp=69;mat_pep_desc=nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only;ao=4;nt_name=g.C17867T;ps_exc=;chrom_region=ORF1b;protein=NSP14;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	18449	18449	.	+	.	ID=ID_127;Name=S6062I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.S6062I;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=3'-to-5' exonuclease;dp=69;mat_pep_desc=nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only;ao=2;nt_name=g.G18185T;ps_exc=;chrom_region=ORF1b;protein=NSP14;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	18508	18508	.	+	.	ID=ID_128;Name=L6082F;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.L6082F;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=3'-to-5' exonuclease;dp=69;mat_pep_desc=nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only;ao=3;nt_name=g.C18244T;ps_exc=;chrom_region=ORF1b;protein=NSP14;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	18570	18570	.	+	.	ID=ID_129;Name=L6102L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.L6102L;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=3'-to-5' exonuclease;dp=69;mat_pep_desc=nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only;ao=1;nt_name=g.C18306T;ps_exc=;chrom_region=ORF1b;protein=NSP14;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	18744	18744	.	+	.	ID=ID_130;Name=Y6160Y;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.Y6160Y;mat_pep_acc=;ro=67;Reference_seq=C;mat_pep_id=3'-to-5' exonuclease;dp=69;mat_pep_desc=nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only;ao=2;nt_name=g.C18480T;ps_exc=;chrom_region=ORF1b;protein=NSP14;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	18777	18777	.	+	.	ID=ID_131;Name=Q6171Q;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.Q6171Q;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=3'-to-5' exonuclease;dp=69;mat_pep_desc=nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only;ao=1;nt_name=g.A18513G;ps_exc=;chrom_region=ORF1b;protein=NSP14;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	19072	19072	.	+	.	ID=ID_132;Name=D6270Y;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.D6270Y;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=3'-to-5' exonuclease;dp=69;mat_pep_desc=nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only;ao=2;nt_name=g.G18808T;ps_exc=;chrom_region=ORF1b;protein=NSP14;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	19220	19220	.	+	.	ID=ID_133;Name=A6319V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.A6319V;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=3'-to-5' exonuclease;dp=69;mat_pep_desc=nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only;ao=69;nt_name=g.C18956T;ps_exc=;chrom_region=ORF1b;protein=NSP14;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	19524	19524	.	+	.	ID=ID_134;Name=L6420L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.L6420L;mat_pep_acc=;ro=48;Reference_seq=C;mat_pep_id=3'-to-5' exonuclease;dp=49;mat_pep_desc=nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only;ao=1;nt_name=g.C19260T;ps_exc=;chrom_region=ORF1b;protein=NSP14;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.02040816326530612;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	19677	19677	.	+	.	ID=ID_135;Name=Q6471H;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.Q6471H;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=endoRNAse;dp=69;mat_pep_desc=nsp15-A1 and nsp15B-NendoU, produced by pp1ab only;ao=1;nt_name=g.G19413T;ps_exc=;chrom_region=ORF1b;protein=NSP15;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	19962	19962	.	+	.	ID=ID_136;Name=T6566T;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.T6566T;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=endoRNAse;dp=69;mat_pep_desc=nsp15-A1 and nsp15B-NendoU, produced by pp1ab only;ao=1;nt_name=g.G19698T;ps_exc=;chrom_region=ORF1b;protein=NSP15;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	20292	20292	.	+	.	ID=ID_137;Name=R6676R;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.R6676R;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=endoRNAse;dp=68;mat_pep_desc=nsp15-A1 and nsp15B-NendoU, produced by pp1ab only;ao=1;nt_name=g.G20028T;ps_exc=;chrom_region=ORF1b;protein=NSP15;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014705882352941176;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	20385	20385	.	+	.	ID=ID_138;Name=A6707A;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.A6707A;mat_pep_acc=;ro=67;Reference_seq=T;mat_pep_id=endoRNAse;dp=68;mat_pep_desc=nsp15-A1 and nsp15B-NendoU, produced by pp1ab only;ao=1;nt_name=g.T20121C;ps_exc=;chrom_region=ORF1b;protein=NSP15;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014705882352941176;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	20555	20555	.	+	.	ID=ID_139;Name=S6764Y;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.S6764Y;mat_pep_acc=;ro=64;Reference_seq=C;mat_pep_id=endoRNAse;dp=69;mat_pep_desc=nsp15-A1 and nsp15B-NendoU, produced by pp1ab only;ao=5;nt_name=g.C20291A;ps_exc=;chrom_region=ORF1b;protein=NSP15;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.07246376811594203;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	20578	20578	.	+	.	ID=ID_140;Name=V6772L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.V6772L;mat_pep_acc=;ro=56;Reference_seq=G;mat_pep_id=endoRNAse;dp=69;mat_pep_desc=nsp15-A1 and nsp15B-NendoU, produced by pp1ab only;ao=13;nt_name=g.G20314T;ps_exc=;chrom_region=ORF1b;protein=NSP15;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.18840579710144928;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	20771	20771	.	+	.	ID=ID_141;Name=K6836R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.K6836R;mat_pep_acc=;ro=59;Reference_seq=A;mat_pep_id=2'-O-ribose methyltransferase;dp=60;mat_pep_desc=nsp16_OMT, 2'-o-MT, produced by pp1ab only;ao=1;nt_name=g.A20507G;ps_exc=;chrom_region=ORF1b;protein=NSP16;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.016666666666666666;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	20799	20799	.	+	.	ID=ID_142;Name=Y6845Y;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=ORF1ab;aa_name=p.Y6845Y;mat_pep_acc=;ro=57;Reference_seq=T;mat_pep_id=2'-O-ribose methyltransferase;dp=60;mat_pep_desc=nsp16_OMT, 2'-o-MT, produced by pp1ab only;ao=3;nt_name=g.T20535C;ps_exc=;chrom_region=ORF1b;protein=NSP16;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.05;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21008	21008	.	+	.	ID=ID_143;Name=T6915I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.T6915I;mat_pep_acc=;ro=59;Reference_seq=C;mat_pep_id=2'-O-ribose methyltransferase;dp=60;mat_pep_desc=nsp16_OMT, 2'-o-MT, produced by pp1ab only;ao=1;nt_name=g.C20744T;ps_exc=;chrom_region=ORF1b;protein=NSP16;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.016666666666666666;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21137	21137	.	+	.	ID=ID_144;Name=K6958R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=ORF1ab;aa_name=p.K6958R;mat_pep_acc=;ro=59;Reference_seq=A;mat_pep_id=2'-O-ribose methyltransferase;dp=60;mat_pep_desc=nsp16_OMT, 2'-o-MT, produced by pp1ab only;ao=1;nt_name=g.A20873G;ps_exc=;chrom_region=ORF1b;protein=NSP16;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.016666666666666666;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	complex	21304	21304	.	+	.	ID=ID_145;Name=R7014N;ps_filter=;Variant_seq=AA;mutation_type=;vcf_gene=ORF1ab;aa_name=p.R7014N;mat_pep_acc=;ro=58;Reference_seq=CG;mat_pep_id=2'-O-ribose methyltransferase;dp=59;mat_pep_desc=nsp16_OMT, 2'-o-MT, produced by pp1ab only;ao=1;nt_name=g.CG21040_21041AA;ps_exc=;chrom_region=ORF1b;protein=NSP16;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.01694915254237288;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21575	21575	.	+	.	ID=ID_146;Name=L5F;ps_filter=mask;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L5F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C13T;ps_exc=highly_homoplasic;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='D614G';function_description=Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.1x decrease in binding (KD) relative to D614G.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21575	21575	.	+	.	ID=ID_146;Name=L5F;ps_filter=mask;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L5F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C13T;ps_exc=highly_homoplasic;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=convalescent plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='D614G';function_description=No change in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21575	21575	.	+	.	ID=ID_146;Name=L5F;ps_filter=mask;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L5F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C13T;ps_exc=highly_homoplasic;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=vaccinee plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='D614G';function_description=1.23x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.1x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21707	21707	.	+	.	ID=ID_147;Name=H49Y;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.H49Y;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C145T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21742	21742	.	+	.	ID=ID_148;Name=S60S;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=S;aa_name=p.S60S;mat_pep_acc=;ro=50;Reference_seq=C;mat_pep_id=;dp=52;mat_pep_desc=;ao=2;nt_name=g.C180T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.038461538461538464;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21778	21778	.	+	.	ID=ID_149;Name=G72G;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=S;aa_name=p.G72G;mat_pep_acc=;ro=51;Reference_seq=G;mat_pep_id=;dp=52;mat_pep_desc=;ao=1;nt_name=g.G216C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.019230769230769232;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21846	21846	.	+	.	ID=ID_150;Name=T95I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.T95I;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=52;mat_pep_desc=;ao=52;nt_name=g.C284T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='D614G';function_description=Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.33x decrease in binding (KD) relative to D614G.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21846	21846	.	+	.	ID=ID_150;Name=T95I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.T95I;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=52;mat_pep_desc=;ao=52;nt_name=g.C284T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='D614G';function_description=No change in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21846	21846	.	+	.	ID=ID_150;Name=T95I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.T95I;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=52;mat_pep_desc=;ao=52;nt_name=g.C284T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccinee plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='D614G';function_description=1.16x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.02x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21987	21987	.	+	.	ID=ID_151;Name=G142D;ps_filter=mask;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G142D;mat_pep_acc=;ro=0;Reference_seq=G;mat_pep_id=;dp=43;mat_pep_desc=;ao=43;nt_name=g.G425A;ps_exc=amplicon_drop_or_primer_artefact,back_to_ref;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=monoclonal antibody serial passage escape;source=https://doi.org/10.1101/2021.01.14.426475;citation=McCallum et al. (2021);comb_mutation=;function_description=Escape mutation against Spike N terminal domain antigenic supersite i mAbs S2M28, S2X28, S2X333;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	21987	21987	.	+	.	ID=ID_151;Name=G142D;ps_filter=mask;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G142D;mat_pep_acc=;ro=0;Reference_seq=G;mat_pep_id=;dp=43;mat_pep_desc=;ao=43;nt_name=g.G425A;ps_exc=amplicon_drop_or_primer_artefact,back_to_ref;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=monoclonal antibody serial passage escape;source=https://www.biorxiv.org/content/10.1101/2021.01.19.427324v1;citation=Suryadevara et al. (2021);comb_mutation=;function_description=Selected twice in passage with mAb COV2-2489.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22021	22021	.	+	.	ID=ID_152;Name=M153I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.M153I;mat_pep_acc=;ro=53;Reference_seq=G;mat_pep_id=;dp=57;mat_pep_desc=;ao=4;nt_name=g.G459T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.07017543859649122;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22024	22024	.	+	.	ID=ID_153;Name=E154E;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=S;aa_name=p.E154E;mat_pep_acc=;ro=56;Reference_seq=A;mat_pep_id=;dp=57;mat_pep_desc=;ao=1;nt_name=g.A462G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.017543859649122806;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22081	22081	.	+	.	ID=ID_154;Name=Q173H;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.Q173H;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G519T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22224	22224	.	+	.	ID=ID_155;Name=S221L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S221L;mat_pep_acc=;ro=67;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.C662T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22272	22272	.	+	.	ID=ID_156;Name=R237M;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.R237M;mat_pep_acc=;ro=66;Reference_seq=G;mat_pep_id=;dp=67;mat_pep_desc=;ao=1;nt_name=g.G710T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014925373134328358;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22411	22411	.	+	.	ID=ID_157;Name=G283G;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=S;aa_name=p.G283G;mat_pep_acc=;ro=63;Reference_seq=A;mat_pep_id=;dp=67;mat_pep_desc=;ao=4;nt_name=g.A849G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.05970149253731343;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22597	22597	.	+	.	ID=ID_158;Name=T345T;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=S;aa_name=p.T345T;mat_pep_acc=;ro=67;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.C1035T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22713	22713	.	+	.	ID=ID_159;Name=P384L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.P384L;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C1151T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=syncytium formation;source=https://dx.doi.org/10.3390%2Fv13040633;citation=Kim et al. (2021);comb_mutation='D614G';function_description=Slight increase in Vero cell-cell membrane fusion assay under infection with VSV pseudotyped virus relative to wild type, no change relative to D614G.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22713	22713	.	+	.	ID=ID_159;Name=P384L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.P384L;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C1151T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=trafficking;source=https://dx.doi.org/10.3390%2Fv13040633;citation=Kim et al. (2021);comb_mutation='D614G';function_description=~4x more efficient S2 domain cleavage compared to wild type, no change relative to D614G alone in Caco-2 cells, mid-range of three cell line tested (Vero and Calu-3).;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22713	22713	.	+	.	ID=ID_159;Name=P384L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.P384L;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C1151T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=trafficking;source=https://dx.doi.org/10.3390%2Fv13040633;citation=Kim et al. (2021);comb_mutation='D614G';function_description=No change in infectivity (24h) relative to D614G alone in Caco-2 cells, Vero or Calu-3.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22899	22899	.	+	.	ID=ID_160;Name=G446V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G446V;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.G1337T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=antibody epitope effects;source=https://www.biorxiv.org/content/10.1101/2020.11.06.372037v2;citation=Liu et al. (2021);comb_mutation=;function_description=Mutant screen in neutralization assay with a broad range of monoclonal antibodies shows resistence to more than one antibody.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22899	22899	.	+	.	ID=ID_160;Name=G446V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G446V;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.G1337T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=antibody epitope effects;source=https://science.sciencemag.org/content/371/6531/823;citation=Rappazzo et al. (2021);comb_mutation=;function_description=Massive reduction in binding efficiency vs wild type for mAb REGN10933.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22899	22899	.	+	.	ID=ID_160;Name=G446V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G446V;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.G1337T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=pharmaceutical effectiveness;source=https://www.biorxiv.org/content/10.1101/2021.04.27.440939v1;citation=Engelhart et al. (2021);comb_mutation=;function_description=Cligavimab lost ~16x binding against this isolated mutation. Imdevimab lost ~16x binding against this isolated mutation (the only RBD variant to do so).;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22899	22899	.	+	.	ID=ID_160;Name=G446V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G446V;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.G1337T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=convalescent plasma escape;source=https://doi.org/10.1016/j.chom.2021.02.003;citation=Greaney et al. (2021);comb_mutation=;function_description=In 2 of 11 subjects' convalescent sera in an early+late mutational landscape analysis of the RBD,  the early serum timepoint shows significant resistance (~10x or more), but both abate by the late timepoint (~3m)  presumably through immune cell somatic mutation evolution.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22899	22899	.	+	.	ID=ID_160;Name=G446V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G446V;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.G1337T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=convalescent plasma escape;source=https://www.biorxiv.org/content/10.1101/2020.11.06.372037v2;citation=Liu et al. (2021);comb_mutation=;function_description=Ablation of neutralization capability of 3 convalescent sera tested, 1 improvement.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22899	22899	.	+	.	ID=ID_160;Name=G446V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G446V;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.G1337T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=convalescent plasma escape;source=https://www.sciencedirect.com/science/article/abs/pii/S0092867420308771;citation=Li et al. (2020);comb_mutation=;function_description=Resistant to a pool of 10 convalescent sera (but less than 4x, a typical threshold for definition of escape);heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22899	22899	.	+	.	ID=ID_160;Name=G446V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G446V;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.G1337T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=monoclonal antibody serial passage escape;source=https://doi.org/10.1016/j.chom.2020.11.007;citation=Greaney et al. (2020);comb_mutation=;function_description=Most effective mutant against this position in the RBD for highly neutralizing COV2-2499 monoclonal antibody Most but only mildly effective mutant against this position in the RBD for highly neutralizing COV2-2096 monoclonal antibody;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=T cell evasion;source=https://www.biorxiv.org/content/10.1101/2021.04.02.438288v1.full.pdf;citation=Motozono et al. (2021);comb_mutation=;function_description=L452R derivative virus did not induce IFN-gamma expression even at the highest concentration tested (10 nM) in two different A*24:02 convalescent sera  donor plasma (linear epitope NYNYLYRLF 448,456).;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_162;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=symptom prevalence;source=https://www.biorxiv.org/content/10.1101/2021.05.05.442760v1;citation=Yadav et al. (2021);comb_mutation='E484Q', 'P681R';function_description=Gross examination of 3+3 hamster lung specimens showed pronounced congestion and hemorrhages on days 5 and 7 post-infection in the case of the B.1.617.1 as compared with the B.1. The lung lesions with  the B.1 variant were minimal to mild whereas with B.1.617.1 they were moderate. For B.1 pneumonic changes were minimal to mild (inflammatory cell infiltration, focal consolidation and mild congestion). The pronounced changes (moderate to severe) with mononuclear infiltration in the alveolar interstitial space, interstitial septal thickening, consolidation and pneumocyte hyperplasia were observed with B.1.617.1 variant consistently.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=antibody epitope effects;source=https://www.biorxiv.org/content/10.1101/2021.03.22.436481v1;citation=Sun et al. (2021);comb_mutation=;function_description=~20% (ELISA significance threshold) drop in antibody binding (ELISA) by this variant against monoclonal antibody VH ab6.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=antibody epitope effects;source=https://www.biorxiv.org/content/10.1101/2021.03.31.437925v1;citation=McCallum et al. (2021);comb_mutation=;function_description=10 of 14 RBD-specific mAbs that showed at least 10-fold reduced neutralization of B.1.427/B.1.429 variant pseudotype (S13I, W152C, and L452R) were also found to poorly bind to just a L452R RBD mutant, demonstrating a role for this mutation as an escape mechanism for certain RBD-targeting mAbs.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=antibody epitope effects;source=https://www.biorxiv.org/content/10.1101/2020.11.06.372037v2;citation=Liu et al. (2021);comb_mutation=;function_description=Mutant screen in neutralization assay with a broad range of monoclonal antibodies shows resistence to more than one antibody.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=antibody epitope effects;source=https://www.sciencedirect.com/science/article/abs/pii/S0092867420308771;citation=Li et al. (2020);comb_mutation=;function_description=Resistent to some neutralizing antibodies: mAbs X593 and P2B-2F6;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_163;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='D614G';function_description=Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 2.66x increase in binding (KD) relative to D614G.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_164;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='E484Q', 'D614G';function_description=Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant combination (representing lineage B.1.617) showed a 1.85x increase  in binding (KD) relative to D614G. [exact variant list not provided in manuscript, is inferred fro common knowledge];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.04.02.438288v1;citation=Motozono et al. (2021);comb_mutation=;function_description=~1.7-fold increase in binding affinity vs wild type.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://www.biorxiv.org/content/10.1101/2021.05.08.443253v1;citation=Ferriera et al (2021);comb_mutation=;function_description=This variant alone shows a ~5x decrease in cell entry efficiency (RLU measurement in 293T cells) compared to D614G. [listed as L454R in Figure, but L452R in text, also text  suggests not statistucally significant, but error bars say otherwise in Figure 4];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://www.biorxiv.org/content/10.1101/2021.04.02.438288v1;citation=Motozono et al. (2021);comb_mutation=;function_description=Increased stability of RBD expression in yeast, suggesting increased Spike protein stability.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://www.medrxiv.org/content/10.1101/2021.03.07.21252647v1;citation=Deng et al. (2021);comb_mutation=;function_description=We observed increased entry by pseudoviruses carrying the L452R mutation compared to D614G alone,  with a 6.7 to 22.5-fold increase in 293T cells and a 5.8 to 14.7-fold increase in human airway organoids.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_162;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=viral load;source=https://www.biorxiv.org/content/10.1101/2021.05.05.442760v1;citation=Yadav et al. (2021);comb_mutation='E484Q', 'P681R';function_description=In 9 infected hamsters each for B.1 and B.1.617.1, no significant change in viral load or subgenomic RNA levels were detected. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=pharmaceutical effectiveness;source=https://www.biorxiv.org/content/10.1101/2021.03.31.437925v1;citation=McCallum et al. (2021);comb_mutation=;function_description=Bamlanivimab (LY-CoV555) entirely lost its neutralizing activity due to the central location of L452R in the epitopes recognized by this mAb. Regdanvimab (CT-P59), and to a smaller extent etesevimab, showed a reduction in neutralization potency.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=pharmaceutical effectiveness;source=https://www.biorxiv.org/content/10.1101/2021.04.27.440939v1;citation=Engelhart et al. (2021);comb_mutation=;function_description=Bamlanivimab (LY-CoV555) lost ~5x binding against this isolated mutation. Cligavimab lost ~4x binding against this isolated mutation. Regdanvimab lost ~4x binding against this isolated mutation.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_163;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma escape;source=https://www.medrxiv.org/content/10.1101/2021.08.09.21261704v1;citation=Wilhelm et al. (2021);comb_mutation='D614G';function_description=Relative to B.1, Epsilon (B.1.417/429) shows 1.74x-2.35x decrease in neutralization efficiency by convalescent plasma [no cohort details provided];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_164;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma escape;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='E484Q', 'D614G';function_description=Pseudotyped viruses for B.1.617 was 2.3-fold resistant to neutralization by convalescent sera compared to wild type - a finding that was similar to that of the 3-fold resistance of the South Africa B.1.351 variant using the same assay. The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617. [details on the convalescent patient sera collection are not abundantly clear in the preprint];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma escape;source=https://www.biorxiv.org/content/10.1101/2021.04.22.441007v1;citation=Alenquer et al. (2021);comb_mutation=;function_description=Observed ~2x decrease on average in 16 health workers' convalescent sera.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma escape;source=https://www.biorxiv.org/content/10.1101/2020.11.06.372037v2;citation=Liu et al. (2021);comb_mutation=;function_description=Ablation of neutralization capability of 3 of 4 convalescent sera tested, the other is significantly hindered.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_165;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=transmissibility;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='E484Q', 'P681R', 'D614G';function_description=Normalized for particle number, on ACE2.293T cells showed that the B.1.617 spike protein was >2-fold increase in infectivity relative to D614G wild type.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_163;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=transmissibility;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='D614G';function_description=Increased infectivity of the B.1.617 spike was attributed to L452R, which itself caused a 3.5-fold increase in infectivity relative to D614G wild type.  [In combination with E484Q caused a lower 3-fold increase];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_164;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=transmissibility;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='E484Q', 'D614G';function_description=The combination caused a 3-fold increase in infectivity relative to D614G wild type. [compare to 3.5x for L452R alone];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_163;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='D614G';function_description=2.15x increase in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_164;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='E484Q', 'D614G';function_description=This variant combination (representing lineage B.1.617) showed a 1.22x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 8 months post-symptom-onset. [exact variant list not provided in manuscript, is inferred fro common knowledge];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_163;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://www.medrxiv.org/content/10.1101/2021.08.09.21261704v1;citation=Wilhelm et al. (2021);comb_mutation='D614G';function_description=Relative to B.1, Epsilon (B.1.417/429) shows 1.74x-2.35x decrease in neutralization efficiency by 18 vaccinee sera (BNT162b2 and mRNA1273).;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_164;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='E484Q', 'D614G';function_description=Pseudotyped viruses for B.1.617 was 4-fold resistant to neutralization by 6 BNT162b2 vaccine sera 28 days post-booster compared to wild type - a finding that was similar to that of the 3.4-fold resistance of the South Africa B.1.351 variant using the same assay. Neutralization by 3 Moderna vaccine sera 28 days post-booster was 5-fold resistant (vs. 2.2-fold for B.1.351). The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_164;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='E484Q', 'D614G';function_description=1.4x reduction in neutralization (ID50) in sera 3 weeks after one dose of Pfizer/BioNTech BNT162b2 (up to 5 naive and post infection vaccinees);heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_166;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://www.biorxiv.org/content/10.1101/2021.05.08.443253v1;citation=Ferreira et al. (2021);comb_mutation='E484Q';function_description=Nine stored sera from Pfizer BNT162b2 vaccinees were tested against a range of spike mutation bearing PV. E484Q had a ~5x drop in neutralization (vs ~10x for E484K). When E484Q and L452R were combined, the fold change was significant, but similar to that of L452R alone (~2x), suggesting no evidence for an additive effect [perhaps even E484Q effect dilution]. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://www.biorxiv.org/content/10.1101/2021.05.08.443253v1;citation=Ferreira et al. (2021);comb_mutation=;function_description=Nine stored sera from Pfizer BNT162b2 vaccinees were tested against a range of spike mutation bearing PV. L452R conferred about a two-fold reduction in neutralisation by vaccine sera, but was not statistically significant with this sample size.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://www.medrxiv.org/content/10.1101/2021.04.14.21255431v2;citation=Jacobson et al. (2021);comb_mutation=;function_description=The presence of this variant in 189 post-mRNA-vaccination COVID-19 cases was proportionally in line with lineage prevalence in Northen California during the study period, suggesting no effect of these variants on immune escape.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=monoclonal antibody serial passage escape;source=https://www.biorxiv.org/content/10.1101/2021.02.17.431683v1;citation=Starr et al. (2021);comb_mutation=;function_description=Escape mutation against monoclonal antibody LY-CoV555 (antibody that forms the basis for Eli Lilly's bamlanivimab);heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=monoclonal antibody serial passage escape;source=https://doi.org/10.1016/j.chom.2020.11.007;citation=Greaney et al. (2020);comb_mutation=;function_description=Ranked effective mutant against this position in the RBD for highly neutralizing COV2-2096;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=monoclonal antibody serial passage escape;source=https://www.biorxiv.org/content/10.1101/2021.01.15.426911v2;citation=Wang et al. (2021);comb_mutation=;function_description=Class 2/3 antibody C628 and class 2 antibody C643 selected for the emergence of the L452R mutation in vitro.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=gene expression increase;source=https://doi.org/10.1016/j.cell.2020.08.012;citation=Starr et al. (2020);comb_mutation=;function_description=Experimentally, Spike gene expression increased 0.32 fold;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_161;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=virion structure;source=https://www.biorxiv.org/content/10.1101/2021.03.24.436850v1;citation=Spratt et al. (2021);comb_mutation=;function_description=Estimated free energy change (ddG) for this variant is -0.67 kcal/mol (i.e. destabilizing relative to wild type) ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_163;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccinee plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='D614G';function_description=1.05x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects. 1.16x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22917	22917	.	+	.	ID=ID_164;Name=L452R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.L452R;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T1355G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccinee plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='E484Q', 'D614G';function_description=This variant combination (representing lineage B.1.617) showed a 1.30x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.   1.18x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees. [exact variant list not provided in manuscript, is inferred fro common knowledge];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22988	22988	.	+	.	ID=ID_167;Name=G476S;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G476S;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1426A;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	complex	22992	22992	.	+	.	ID=ID_168;Name=T478K;ps_filter=;Variant_seq=ACAA;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.T478K;mat_pep_acc=;ro=0;Reference_seq=GCAC;mat_pep_id=;dp=69;mat_pep_desc=;ao=3;nt_name=g.C1433A;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=immunosuppression variant emergence;source=https://www.nejm.org/doi/full/10.1056/NEJMc2031364;citation=Choi et al. (2020);comb_mutation=;function_description=Combination of RBD mutations appeared (day 75) and persisted in chronic (152 day) SARS-CoV-2 infection of immunocompromised patient with severe antiphospholipid syndrome complicated by diffuse alveolar hemorrhage, who was receiving anticoagulation therapy, glucocorticoids, cyclophosphamide, and intermittent rituximab and eculizumab. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	22992	22992	.	+	.	ID=ID_169;Name=ST477NK;ps_filter=;Variant_seq=GCAA;mutation_type=;vcf_gene=S;aa_name=p.ST477NK;mat_pep_acc=;ro=0;Reference_seq=GCAC;mat_pep_id=;dp=69;mat_pep_desc=;ao=66;nt_name=g.GCAC1430_1433ACAA;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.9565217391304348;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23010	23010	.	+	.	ID=ID_170;Name=V483A;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.V483A;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1448C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=antibody epitope effects;source=https://www.sciencedirect.com/science/article/abs/pii/S0092867420308771;citation=Li et al. (2020);comb_mutation=;function_description=Resistent to some neutralizing antibodies: mAbs X593 and P2B-2F6;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23010	23010	.	+	.	ID=ID_170;Name=V483A;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.V483A;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1448C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=antibody epitope effects;source=https://www.biorxiv.org/content/10.1101/2020.11.03.367391v2;citation=Gaebler et al. (2021);comb_mutation=;function_description=Ablates binding by class 3 mAbs such as C135 that do not directly interfere with ACE2 binding, but clonal somatic mutations of memory B cells at 6.2 months (evolving humoral immune response) show pronounced increase in binding to the variant.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23010	23010	.	+	.	ID=ID_170;Name=V483A;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.V483A;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1448C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=gene expression increase;source=https://doi.org/10.1016/j.cell.2020.08.012;citation=Starr et al. (2020);comb_mutation=;function_description=Experimentally, Spike gene expression increased 0.09 fold;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_162;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=symptom prevalence;source=https://www.biorxiv.org/content/10.1101/2021.05.05.442760v1;citation=Yadav et al. (2021);comb_mutation='L452R', 'P681R';function_description=Gross examination of 3+3 hamster lung specimens showed pronounced congestion and hemorrhages on days 5 and 7 post-infection in the case of the B.1.617.1 as compared with the B.1. The lung lesions with  the B.1 variant were minimal to mild whereas with B.1.617.1 they were moderate. For B.1 pneumonic changes were minimal to mild (inflammatory cell infiltration, focal consolidation and mild congestion). The pronounced changes (moderate to severe) with mononuclear infiltration in the alveolar interstitial space, interstitial septal thickening, consolidation and pneumocyte hyperplasia were observed with B.1.617.1 variant consistently.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_171;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=antibody epitope effects;source=https://www.biorxiv.org/content/10.1101/2021.03.22.436481v1;citation=Sun et al. (2021);comb_mutation=;function_description=>20% (ELISA significance threshold) drop in antibody binding by this variant against monoclonal antibody VH-Fc ab8.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_164;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R', 'D614G';function_description=Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant combination (representing lineage B.1.617) showed a 1.85x increase  in binding (KD) relative to D614G. [exact variant list not provided in manuscript, is inferred fro common knowledge];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_171;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=trafficking;source=https://www.biorxiv.org/content/10.1101/2021.05.08.443253v1;citation=Ferriera et al (2021);comb_mutation=;function_description=This variant alone shows a 10x decrease in cell entry efficiency (RLU measurement in 293T cells) compared to D614G. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_162;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=viral load;source=https://www.biorxiv.org/content/10.1101/2021.05.05.442760v1;citation=Yadav et al. (2021);comb_mutation='L452R', 'P681R';function_description=In 9 infected hamsters each for B.1 and B.1.617.1, no significant change in viral load or subgenomic RNA levels were detected. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_171;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=pharmaceutical effectiveness;source=https://www.biorxiv.org/content/10.1101/2021.04.27.440939v1;citation=Engelhart et al. (2021);comb_mutation=;function_description=Bamlanivimab (LY-CoV555) lost ~20x binding against this isolated mutation. Casirivimab lost ~4x binding against this isolated mutation.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_164;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=convalescent plasma escape;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='L452R', 'D614G';function_description=Pseudotyped viruses for B.1.617 was 2.3-fold resistant to neutralization by convalescent sera compared to wild type - a finding that was similar to that of the 3-fold resistance of the South Africa B.1.351 variant using the same assay. The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617. [details on the convalescent patient sera collection are not abundantly clear in the preprint];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_171;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=convalescent plasma escape;source=https://doi.org/10.1016/j.chom.2021.02.003;citation=Greaney et al. (2021);comb_mutation=;function_description=In 3 of 11 subjects' convalescent sera in an early+late mutational landscape analysis of the RBD,  E484Q shows a notably resistant profile, comparable to or even more resistant than E484K at  later time points (i.e. more resistant to immune cell somatic mutation evolution), see Figure 5a,b. Subject C 32 days post-infection showed >>10 fold reduction in neutralization, reducing to ~10-fold by day 104. Subject B 26 days post-infection showed ~10 fold reduction in neutralization, reducing to ~4x at day 113. Notably, Subject B also showed smaller than typical (~10 vs 30+ fold) reduction in one-month neutralization by E484K at day 32,  and no E484K immune escape at day 104. Subject I 26 days post-infection showed ~10 fold reduction in neutralization, with no reduction in escape at day 102. Notably, Subject I also showed smaller than typical (~10 vs 30+ fold) reduction in one-month neutralization by E484K at day 26,  and no E484K immune escape at day 102.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_165;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=transmissibility;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='L452R', 'P681R', 'D614G';function_description=Normalized for particle number, on ACE2.293T cells showed that the B.1.617 spike protein was >2-fold increase in infectivity relative to D614G wild type.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_164;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=transmissibility;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='L452R', 'D614G';function_description=The combination caused a 3-fold increase in infectivity relative to D614G wild type. [compare to 3.5x for L452R alone];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_164;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=convalescent plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R', 'D614G';function_description=This variant combination (representing lineage B.1.617) showed a 1.22x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 8 months post-symptom-onset. [exact variant list not provided in manuscript, is inferred fro common knowledge];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_164;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=vaccine neutralization efficacy;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='L452R', 'D614G';function_description=Pseudotyped viruses for B.1.617 was 4-fold resistant to neutralization by 6 BNT162b2 vaccine sera 28 days post-booster compared to wild type - a finding that was similar to that of the 3.4-fold resistance of the South Africa B.1.351 variant using the same assay. Neutralization by 3 Moderna vaccine sera 28 days post-booster was 5-fold resistant (vs. 2.2-fold for B.1.351). The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_164;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=vaccine neutralization efficacy;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R', 'D614G';function_description=1.4x reduction in neutralization (ID50) in sera 3 weeks after one dose of Pfizer/BioNTech BNT162b2 (up to 5 naive and post infection vaccinees);heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_166;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=vaccine neutralization efficacy;source=https://www.biorxiv.org/content/10.1101/2021.05.08.443253v1;citation=Ferreira et al. (2021);comb_mutation='L452R';function_description=Nine stored sera from Pfizer BNT162b2 vaccinees were tested against a range of spike mutation bearing PV. E484Q had a ~5x drop in neutralization (vs ~10x for E484K). When E484Q and L452R were combined, the fold change was significant, but similar to that of L452R alone (~2x), suggesting no evidence for an additive effect [perhaps even E484Q effect dilution]. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_171;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=monoclonal antibody serial passage escape;source=https://www.biorxiv.org/content/10.1101/2021.02.17.431683v1;citation=Starr et al. (2021);comb_mutation=;function_description=Escape mutation against monoclonal antibody LY-CoV555 (antibody that forms the basis for Eli Lilly's bamlanivimab);heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23012	23012	.	+	.	ID=ID_164;Name=E484Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E484Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1450C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=vaccinee plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R', 'D614G';function_description=This variant combination (representing lineage B.1.617) showed a 1.30x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.   1.18x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees. [exact variant list not provided in manuscript, is inferred fro common knowledge];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23042	23042	.	+	.	ID=ID_172;Name=S494P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S494P;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1480C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=immunosuppression variant emergence;source=https://www.nejm.org/doi/full/10.1056/NEJMc2031364;citation=Choi et al. (2020);comb_mutation=;function_description=Combination of RBD mutations appeared (day 75) and persisted in chronic (152 day) SARS-CoV-2 infection of immunocompromised patient with severe antiphospholipid syndrome complicated by diffuse alveolar hemorrhage, who was receiving anticoagulation therapy, glucocorticoids, cyclophosphamide, and intermittent rituximab and eculizumab. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23042	23042	.	+	.	ID=ID_172;Name=S494P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S494P;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1480C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=antibody epitope effects;source=https://www.biorxiv.org/content/10.1101/2020.11.06.372037v2;citation=Liu et al. (2020);comb_mutation=;function_description=Mutant screen in neutralization assay with a broad range of monoclonal antibodies shows resistence to mAb SARS2-01.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23042	23042	.	+	.	ID=ID_172;Name=S494P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S494P;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1480C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=antibody epitope effects;source=https://science.sciencemag.org/content/371/6531/823;citation=Rappazzo et al. (2021);comb_mutation=;function_description=Greater than 10-fold rediuction of binding effeiency vs wild type for mAb LY-CoV555.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23042	23042	.	+	.	ID=ID_172;Name=S494P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S494P;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1480C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=ACE2 receptor binding affinity;source=https://doi.org/10.1016/j.bbrc.2021.01.035;citation=Chakraborty (2021);comb_mutation=;function_description=Using molecular dynamic simulation, the mildly (~1kcal/mol) enhanced binding energy of this variant is primarily  contributed by Tyr505 (4.98 kcal/mol) which is now involved in a strong hydrogen bonding network with Arg393.  Another important energetic contribution comes from the altered orientation of Tyr41 which is now involved with  two hydrogen-bonding interactions with Asp355 and Thr500. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23042	23042	.	+	.	ID=ID_172;Name=S494P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S494P;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1480C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.01.06.425392;citation=Zahradnik et al. (2021);comb_mutation=;function_description=Minor variant selected in late rounds of an in vitro evolution experiment for ACE2 binding. Shown to increase the thermostability but decrease the association rate constant of the RBD to ACE2;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23042	23042	.	+	.	ID=ID_172;Name=S494P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S494P;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1480C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=pharmaceutical effectiveness;source=https://www.biorxiv.org/content/10.1101/2021.04.27.440939v1;citation=Engelhart et al. (2021);comb_mutation=;function_description=Bamlanivimab (LY-CoV555) lost ~8x binding against this isolated mutation. Regdanvimab lost ~32x binding against this isolated mutation.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23042	23042	.	+	.	ID=ID_172;Name=S494P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S494P;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1480C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=convalescent plasma escape;source=http://biorxiv.org/cgi/content/short/2021.04.22.441007;citation=Alenquer et al. (2021);comb_mutation=;function_description=S494P frequently engages in interactions with antibodies but not with ACE2. It reduces antibody  neutralization of all 16 convalescent sera tested, averaging WT ratio of 0.41+-0.08 (less dramatic than E484K).  This amino acid emerges as an additional hotspot for immune evasion and a target for therapies, vaccines and diagnostics. It has emerged independently in multiple lineages.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23042	23042	.	+	.	ID=ID_172;Name=S494P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S494P;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1480C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=convalescent plasma escape;source=https://doi.org/10.1016/j.chom.2021.02.003;citation=Greaney et al. (2021);comb_mutation=;function_description=In 2 of 11 subjects' convalescent sera in an early+late mutational landscape analysis of the RBD,  S484P shows a slightly resistent profile across both timepoints (i.e. resistant to immune cell somatic mutation evolution);heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23042	23042	.	+	.	ID=ID_172;Name=S494P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S494P;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1480C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=convalescent plasma escape;source=https://www.biorxiv.org/content/10.1101/2020.11.06.372037v2;citation=Liu et al. (2021);comb_mutation=;function_description=Mixed bag of positive and negative changes in neutralization capability of all 4 convalescent sera tested.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23042	23042	.	+	.	ID=ID_172;Name=S494P;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.S494P;mat_pep_acc=;ro=65;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.T1480C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=monoclonal antibody serial passage escape;source=https://www.biorxiv.org/content/10.1101/2021.02.17.431683v1;citation=Starr et al. (2021);comb_mutation=;function_description=Escape mutation against monoclonal antibody LY-CoV555 (antibody that forms the basis for Eli Lilly's bamlanivimab);heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23050	23050	.	+	.	ID=ID_173;Name=G496G;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=S;aa_name=p.G496G;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.T1488C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23224	23224	.	+	.	ID=ID_174;Name=E554D;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E554D;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1662T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=immunosuppression variant emergence;source=https://www.medrxiv.org/content/10.1101/2021.05.08.21256775v1;citation=Landis et al. (2021);comb_mutation=;function_description=Studying 94 COVID-19 extended infection cases with genomics April 1 to October 17, 2020, one case developed 23 mutations in a 19 day period, including this combination in Spike.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23267	23267	.	+	.	ID=ID_175;Name=I569V;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.I569V;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.A1705G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23282	23282	.	+	.	ID=ID_176;Name=D574Y;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D574Y;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1720T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23285	23285	.	+	.	ID=ID_177;Name=A575S;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.A575S;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1723T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=immunosuppression variant emergence;source=https://www.medrxiv.org/content/10.1101/2021.05.08.21256775v1;citation=Landis et al. (2021);comb_mutation=;function_description=Studying 94 COVID-19 extended infection cases with genomics April 1 to October 17, 2020, one case developed 23 mutations in a 19 day period, including this combination in Spike.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=syncytium formation;source=https://dx.doi.org/10.3390%2Fv13040633;citation=Kim et al. (2021);comb_mutation=;function_description=Slight increase in Vero cell-cell membrane fusion assay under infection with VSV pseudotyped virus.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_159;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=syncytium formation;source=https://dx.doi.org/10.3390%2Fv13040633;citation=Kim et al. (2021);comb_mutation='P384L';function_description=Slight increase in Vero cell-cell membrane fusion assay under infection with VSV pseudotyped virus relative to wild type, no change relative to D614G.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_146;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L5F';function_description=Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.1x decrease in binding (KD) relative to D614G.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_150;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='T95I';function_description=Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 1.33x decrease in binding (KD) relative to D614G.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_163;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R';function_description=Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant showed a 2.66x increase in binding (KD) relative to D614G.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_164;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=ACE2 receptor binding affinity;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R', 'E484Q';function_description=Using flow cytometry and ACE2 ectodomains-Fc portion IgG complex, this variant combination (representing lineage B.1.617) showed a 1.85x increase  in binding (KD) relative to D614G. [exact variant list not provided in manuscript, is inferred fro common knowledge];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=ACE2 receptor binding affinity;source=https://doi.org/10.1016/j.cell.2020.07.012;citation=Li et al. (2020);comb_mutation=;function_description=In four cell lines (including 293T-hACE2 cells), this mutation combination increases infectivity vs D614G alone;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_179;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='P681R';function_description=Quantification of the band intensities showed that the P681R mutation, which lies near the proteolytic processing site,  caused a small increase in proteolytic processing as measured by a 2-fold decrease in the ratio of S/S2.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://dx.doi.org/10.3390%2Fv13040633;citation=Kim et al. (2021);comb_mutation=;function_description=~4x more efficient S2 domain cleavage compared to wild type in Caco-2 cells, mid-range of three cell line tested (Vero and Calu-3).;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_159;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://dx.doi.org/10.3390%2Fv13040633;citation=Kim et al. (2021);comb_mutation='P384L';function_description=~4x more efficient S2 domain cleavage compared to wild type, no change relative to D614G alone in Caco-2 cells, mid-range of three cell line tested (Vero and Calu-3).;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://dx.doi.org/10.3390%2Fv13040633;citation=Kim et al. (2021);comb_mutation=;function_description=No change in infectivity (24h) relative to D614G alone in Caco-2 cells, Vero or Calu-3.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_159;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://dx.doi.org/10.3390%2Fv13040633;citation=Kim et al. (2021);comb_mutation='P384L';function_description=No change in infectivity (24h) relative to D614G alone in Caco-2 cells, Vero or Calu-3.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://www.biorxiv.org/content/10.1101/2021.01.24.428007v1;citation=Barrett et al. (2021);comb_mutation=;function_description=Circulating variant shown in vitro to not have major defects or enhancement of cell surface protein trafficking (i.e. Spike cleavage or fusion required for cell entry);heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://www.nature.com/articles/s41467-020-19808-4;citation=Zhang et l. (2020);comb_mutation=;function_description=We report here pseudoviruses carrying SG614 enter ACE2-expressing cells more efficiently than wild type (~9-fold).  This increased entry correlates with less S1-domain shedding and higher S-protein incorporation into the virion.  D614G does not alter S-protein binding to ACE2 or neutralization sensitivity of pseudoviruses. Thus, D614G may  increase infectivity by assembling more functional S protein into the virion.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://www.nature.com/articles/s41467-021-21118-2;citation=Ozono et al. (2020);comb_mutation=;function_description=Among S variants tested, the D614G mutant shows the highest cell entry (~3.5x wild type), as supported by  structural and binding analyses. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://doi.org/10.7554/elife.65365;citation=Daniloski et al. (2021);comb_mutation=;function_description=The increased transduction with Spike D614G ranged from 1.3- to 2.4-fold in Caco-2 and Calu-3 cells expressing  endogenous ACE2 and from 1.5- to 7.7-fold in A549ACE2 and Huh7.5ACE2 overexpressing ACE2.  Although there is minimal difference in ACE2 receptor binding between the D614 and G614 Spike variants,  the G614 variant is more resistant to proteolytic cleavage, suggesting a possible mechanism for the increased transduction.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=tissue specific neutralization;source=https://www.nature.com/articles/s41591-021-01318-5;citation=Planas et al. (2021);comb_mutation=;function_description=The nasal mucosa of Pfizer vaccinees with time course collection was evaluated against VSV pseudotypes: results (only one nasal  swab from different previously infected vacinee neutralizing at weeks 3 and 6 against B.1.1.7 and D614G) suggest that vaccinees probably  do not elicit an early humoral response detectable at mucosal surfaces even though sera neutralization was observed. They strengthen the hypothesis that some vaccines may not protect against  viral acquisition and infection of the oralnasal region, but may prevent severe disease associated with viral dissemination in the lower respiratory tract. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=viral load;source=https://www.nature.com/articles/s41586-020-2895-3;citation=Plante et al. (2020);comb_mutation=;function_description=Hamsters infected with SARS-CoV-2 expressing spike(D614G) (G614 virus) produced higher infectious titres in nasal washes and the trachea, but not in the lungs,  supporting clinical evidence showing that the mutation enhances viral loads in the upper respiratory tract of COVID-19 patients and may increase transmission.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_163;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma escape;source=https://www.medrxiv.org/content/10.1101/2021.08.09.21261704v1;citation=Wilhelm et al. (2021);comb_mutation='L452R';function_description=Relative to B.1, Epsilon (B.1.417/429) shows 1.74x-2.35x decrease in neutralization efficiency by convalescent plasma [no cohort details provided];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_164;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma escape;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='L452R', 'E484Q';function_description=Pseudotyped viruses for B.1.617 was 2.3-fold resistant to neutralization by convalescent sera compared to wild type - a finding that was similar to that of the 3-fold resistance of the South Africa B.1.351 variant using the same assay. The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617. [details on the convalescent patient sera collection are not abundantly clear in the preprint];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_165;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=transmissibility;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='L452R', 'E484Q', 'P681R';function_description=Normalized for particle number, on ACE2.293T cells showed that the B.1.617 spike protein was >2-fold increase in infectivity relative to D614G wild type.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_163;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=transmissibility;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='L452R';function_description=Increased infectivity of the B.1.617 spike was attributed to L452R, which itself caused a 3.5-fold increase in infectivity relative to D614G wild type.  [In combination with E484Q caused a lower 3-fold increase];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_164;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=transmissibility;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='L452R', 'E484Q';function_description=The combination caused a 3-fold increase in infectivity relative to D614G wild type. [compare to 3.5x for L452R alone];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_146;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L5F';function_description=No change in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_150;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='T95I';function_description=No change in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_163;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R';function_description=2.15x increase in Spike binding (relative to D614G alone) by 5 plasma collected 8 months post-symptom-onset.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_164;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=convalescent plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R', 'E484Q';function_description=This variant combination (representing lineage B.1.617) showed a 1.22x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 8 months post-symptom-onset. [exact variant list not provided in manuscript, is inferred fro common knowledge];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_163;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://www.medrxiv.org/content/10.1101/2021.08.09.21261704v1;citation=Wilhelm et al. (2021);comb_mutation='L452R';function_description=Relative to B.1, Epsilon (B.1.417/429) shows 1.74x-2.35x decrease in neutralization efficiency by 18 vaccinee sera (BNT162b2 and mRNA1273).;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_164;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='L452R', 'E484Q';function_description=Pseudotyped viruses for B.1.617 was 4-fold resistant to neutralization by 6 BNT162b2 vaccine sera 28 days post-booster compared to wild type - a finding that was similar to that of the 3.4-fold resistance of the South Africa B.1.351 variant using the same assay. Neutralization by 3 Moderna vaccine sera 28 days post-booster was 5-fold resistant (vs. 2.2-fold for B.1.351). The resistance of B.1.617 was caused by the L452R and E484Q mutation, based on results from viruses pseudotyped for individual variants within B.1.617.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_164;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R', 'E484Q';function_description=1.4x reduction in neutralization (ID50) in sera 3 weeks after one dose of Pfizer/BioNTech BNT162b2 (up to 5 naive and post infection vaccinees);heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://dx.doi.org/10.1016%2Fj.chom.2021.03.008;citation=Kuzmina et al. (2021);comb_mutation=;function_description=Using a lentivirus virus pseudotyped with D614G Spike, sera from vaccinated individuals who received the second dose (911 days post-second dose of Pfizer) exhibited a robust  neutralizing potential, with a mean NT50 value of 99,000. This was an average of a 2-fold increase, relative to sera drawn from the  individuals who received one dose of vaccinationmean NT50 dilution of 51,300. Importantly, a 6-fold increase in mean NT50 dilution was  obtained when sera from the first vaccination dose was compared to convalescent sera from cohort with severe disease (NT50 51,000 vs 8,700)  21 to 63 days post-onset. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccine neutralization efficacy;source=https://doi.org/10.1016/j.cell.2021.03.013;citation=Garcia-Beltran et al. (2021);comb_mutation=;function_description=Pseudotyped D614G virus has reduced neutralization activity vs wild type: 1.2x (37 sera Pfizer median 9  days post 2nd dose, 37 sera Moderna median 18 days post 2nd dose). This was NOT significant by ANOVA.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=virion structure;source=https://www.nature.com/articles/s41467-020-19808-4;citation=Zhang et al. (2020);comb_mutation=;function_description=Based on pseudotyped virus experiments, D614G may increase infectivity by assembling more functional S protein into the virion.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	"ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=virion structure;source=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492024/;citation=Yurkovetskiy et al. (2020);comb_mutation=;function_description=CryoEM shows increased proportion of ""one-up"" trimer conformation of Spike proteins on the surface of virions, where the up  conformation is presumed to be more likely to bind ACE2.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;"
NC_045512.2	.	snp	23403	23403	.	+	.	"ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=virion structure;source=https://www.medrxiv.org/content/10.1101/2020.07.22.20159905v2;citation=Weissman et al. (2020);comb_mutation=;function_description=Negative stain EM shows increased proportion of ""one-up"" trimer conformation of Spike proteins on the surface of virions, where the up  conformation is presumed to be more likely to bind ACE2.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;"
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_178;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=virion structure;source=https://www.biorxiv.org/content/10.1101/2021.03.24.436850v1;citation=Spratt et al. (2021);comb_mutation=;function_description=Estimated free energy change (ddG) for this variant is 2.5 kcal/mol (i.e. stabilizing relative to wild type) ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_146;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccinee plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L5F';function_description=1.23x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.1x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_150;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccinee plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='T95I';function_description=1.16x increase in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.  1.02x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_163;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccinee plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R';function_description=1.05x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects. 1.16x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23403	23403	.	+	.	ID=ID_164;Name=D614G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D614G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A1841G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=vaccinee plasma binding;source=https://www.biorxiv.org/content/10.1101/2021.08.04.455140v1;citation=Gong et al. (2021);comb_mutation='L452R', 'E484Q';function_description=This variant combination (representing lineage B.1.617) showed a 1.30x decrease in Spike binding (relative  to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in previously non-seroconverted subjects.   1.18x decrease in Spike binding (relative to D614G alone) by 5 plasma collected 3 weeks after one dose of Pfizer/BioNtech BNT162b2 vaccine in post-infection vaccinees. [exact variant list not provided in manuscript, is inferred fro common knowledge];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23430	23430	.	+	.	ID=ID_180;Name=A623V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.A623V;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=3;nt_name=g.C1868T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23501	23501	.	+	.	ID=ID_181;Name=A647S;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.A647S;mat_pep_acc=;ro=66;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=3;nt_name=g.G1939T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23586	23586	.	+	.	ID=ID_182;Name=Q675R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.Q675R;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.A2024G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23604	23604	.	+	.	ID=ID_162;Name=P681R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.P681R;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.C2042G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=symptom prevalence;source=https://www.biorxiv.org/content/10.1101/2021.05.05.442760v1;citation=Yadav et al. (2021);comb_mutation='L452R', 'E484Q';function_description=Gross examination of 3+3 hamster lung specimens showed pronounced congestion and hemorrhages on days 5 and 7 post-infection in the case of the B.1.617.1 as compared with the B.1. The lung lesions with  the B.1 variant were minimal to mild whereas with B.1.617.1 they were moderate. For B.1 pneumonic changes were minimal to mild (inflammatory cell infiltration, focal consolidation and mild congestion). The pronounced changes (moderate to severe) with mononuclear infiltration in the alveolar interstitial space, interstitial septal thickening, consolidation and pneumocyte hyperplasia were observed with B.1.617.1 variant consistently.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23604	23604	.	+	.	ID=ID_179;Name=P681R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.P681R;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.C2042G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='D614G';function_description=Quantification of the band intensities showed that the P681R mutation, which lies near the proteolytic processing site,  caused a small increase in proteolytic processing as measured by a 2-fold decrease in the ratio of S/S2.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23604	23604	.	+	.	ID=ID_183;Name=P681R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.P681R;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.C2042G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=trafficking;source=https://www.researchgate.net/publication/348943694_The_mutation_P681H_in_the_B117_variant_of_SARS-CoV-2_probably_enhances_viral_entry_and_replication;citation=Maaroufi (2021);comb_mutation=;function_description=This mutation in the first base of the furin clevage site maintains the RXXR recognition motif, and is presumed to enhance cleavage based on the removal of a proline-directed phosphotase recognition site at S680. In a homologuous site in Infectious  Bronchitis Virus (IBV, Gammacoronaviruses), abolition of S680 phosphorylation improves furin cleavage  (and presumably cell entry). [Inference from similar positively charged substitution P681H actually described in the work];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23604	23604	.	+	.	ID=ID_162;Name=P681R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.P681R;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.C2042G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=viral load;source=https://www.biorxiv.org/content/10.1101/2021.05.05.442760v1;citation=Yadav et al. (2021);comb_mutation='L452R', 'E484Q';function_description=In 9 infected hamsters each for B.1 and B.1.617.1, no significant change in viral load or subgenomic RNA levels were detected. ;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23604	23604	.	+	.	ID=ID_165;Name=P681R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.P681R;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.C2042G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=transmissibility;source=https://www.biorxiv.org/content/10.1101/2021.05.14.444076v1;citation=Tada et al. (2021);comb_mutation='L452R', 'E484Q', 'D614G';function_description=Normalized for particle number, on ACE2.293T cells showed that the B.1.617 spike protein was >2-fold increase in infectivity relative to D614G wild type.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23604	23604	.	+	.	ID=ID_183;Name=P681R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.P681R;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.C2042G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=virion structure;source=https://www.biorxiv.org/content/10.1101/2021.02.05.430003v1;citation=Tada et al. (2021);comb_mutation=;function_description=The Ratio of S2 (processed Spike) to full length Spike is higher for this mutation,  due to a drop in the full length Spike measured, suggesting that this mutation compensates for decreased Spike production by improved proteolytic processing. [PG: Inferred by conservative AA substitution of described P681H];heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23610	23610	.	+	.	ID=ID_184;Name=R683L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.R683L;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G2048T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23680	23680	.	+	.	ID=ID_185;Name=A706A;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=S;aa_name=p.A706A;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.T2118C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23770	23770	.	+	.	ID=ID_186;Name=V736V;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=S;aa_name=p.V736V;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.A2208G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	23804	23804	.	+	.	ID=ID_187;Name=E748Q;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.E748Q;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G2242C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	24023	24023	.	+	.	ID=ID_188;Name=L821L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=S;aa_name=p.L821L;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C2461T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	24130	24130	.	+	.	ID=ID_189;Name=N856N;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=S;aa_name=p.N856N;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C2568T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	24368	24368	.	+	.	ID=ID_190;Name=D936H;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D936H;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G2806C;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	24676	24676	.	+	.	ID=ID_191;Name=K1038K;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=S;aa_name=p.K1038K;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.A3114G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25049	25049	.	+	.	ID=ID_192;Name=D1163N;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.D1163N;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G3487A;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25062	25062	.	+	.	ID=ID_193;Name=G1167V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.G1167V;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G3500T;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25234	25234	.	+	.	ID=ID_194;Name=L1224L;ps_filter=;Variant_seq=A;mutation_type=SILENT;vcf_gene=S;aa_name=p.L1224L;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G3672A;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25235	25235	.	+	.	ID=ID_195;Name=I1225V;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=S;aa_name=p.I1225V;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.A3673G;ps_exc=;chrom_region=S;protein=spike;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	complex	25469	25469	.	+	.	ID=ID_196;Name=S26L;ps_filter=;Variant_seq=TAT;mutation_type=MISSENSE;vcf_gene=ORF3a;aa_name=p.S26L;mat_pep_acc=;ro=0;Reference_seq=CAG;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C77T;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25469	25469	.	+	.	ID=ID_197;Name=SD26LY;ps_filter=;Variant_seq=TAG;mutation_type=;vcf_gene=ORF3a;aa_name=p.SD26LY;mat_pep_acc=;ro=0;Reference_seq=CAG;mat_pep_id=;dp=69;mat_pep_desc=;ao=68;nt_name=g.CAG77_79TAT;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.9855072463768116;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25515	25515	.	+	.	ID=ID_198;Name=L41L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF3a;aa_name=p.L41L;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=3;nt_name=g.C123T;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25521	25521	.	+	.	ID=ID_199;Name=F43F;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF3a;aa_name=p.F43F;mat_pep_acc=;ro=67;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.C129T;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25537	25537	.	+	.	ID=ID_200;Name=G49C;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF3a;aa_name=p.G49C;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.G145T;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25595	25595	.	+	.	ID=ID_201;Name=R68I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF3a;aa_name=p.R68I;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G203T;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25603	25603	.	+	.	ID=ID_202;Name=L71L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF3a;aa_name=p.L71L;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C211T;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25658	25658	.	+	.	ID=ID_203;Name=T89I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF3a;aa_name=p.T89I;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C266T;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25842	25842	.	+	.	ID=ID_204;Name=H150H;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=ORF3a;aa_name=p.H150H;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.T450C;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25844	25844	.	+	.	ID=ID_205;Name=T151I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF3a;aa_name=p.T151I;mat_pep_acc=;ro=67;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.C452T;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	25877	25877	.	+	.	ID=ID_206;Name=S162N;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF3a;aa_name=p.S162N;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G485A;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	26023	26023	.	+	.	ID=ID_207;Name=Y211H;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=ORF3a;aa_name=p.Y211H;mat_pep_acc=;ro=57;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=12;nt_name=g.T631C;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.17391304347826086;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	26158	26158	.	+	.	ID=ID_208;Name=V256I;ps_filter=;Variant_seq=A;mutation_type=MISSENSE;vcf_gene=ORF3a;aa_name=p.V256I;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G766A;ps_exc=;chrom_region=ORF3a;protein=ORF3a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	26320	26320	.	+	.	ID=ID_209;Name=F26L;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=E;aa_name=p.F26L;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.T76C;ps_exc=;chrom_region=E;protein=E;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	26365	26365	.	+	.	ID=ID_210;Name=A41S;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=E;aa_name=p.A41S;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G121T;ps_exc=;chrom_region=E;protein=E;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	26681	26681	.	+	.	ID=ID_211;Name=F53F;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=M;aa_name=p.F53F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C159T;ps_exc=;chrom_region=M;protein=M;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	26735	26735	.	+	.	ID=ID_212;Name=Y71Y;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=M;aa_name=p.Y71Y;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C213T;ps_exc=;chrom_region=M;protein=M;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	26767	26767	.	+	.	ID=ID_213;Name=I82T;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=M;aa_name=p.I82T;mat_pep_acc=;ro=0;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.T245C;ps_exc=;chrom_region=M;protein=M;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=homoplasy;source=https://doi.org/10.1080/22221751.2021.1922097;citation=Shen et al. (2021);comb_mutation=;function_description=This mutation presents mainly within the B.1 (44.0%) and B.1.525 (38.1%) lineages.  Currently, 99.7% of the B.1.525 lineage isolates carry the M:I82T mutation. While this mutation is scattered across multiple  phylogenetic clades, most cases cluster in two recent clades, suggesting a likely selective advantage in certain haplotype backgrounds.;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	26822	26822	.	+	.	ID=ID_214;Name=F100F;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=M;aa_name=p.F100F;mat_pep_acc=;ro=62;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=7;nt_name=g.C300T;ps_exc=;chrom_region=M;protein=M;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.10144927536231885;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27005	27005	.	+	.	ID=ID_215;Name=I161I;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=M;aa_name=p.I161I;mat_pep_acc=;ro=65;Reference_seq=C;mat_pep_id=;dp=68;mat_pep_desc=;ao=3;nt_name=g.C483T;ps_exc=;chrom_region=M;protein=M;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.04411764705882353;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27371	27371	.	+	.	ID=ID_216;Name=P57L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF6;aa_name=p.P57L;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C170T;ps_exc=;chrom_region=ORF6;protein=ORF6;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27393	27393	.	+	.	ID=ID_217;Name=g.C-1T;ps_filter=;Variant_seq=T;mutation_type=;vcf_gene=ORF7a;aa_name=;mat_pep_acc=;ro=64;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=5;nt_name=g.C-1T;ps_exc=;chrom_region=intergenic;protein=n/a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.07246376811594203;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27510	27510	.	+	.	ID=ID_218;Name=T39T;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=ORF7a;aa_name=p.T39T;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.A117G;ps_exc=;chrom_region=ORF7a;protein=ORF7a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27561	27561	.	+	.	ID=ID_219;Name=L56L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF7a;aa_name=p.L56L;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G168T;ps_exc=;chrom_region=ORF7a;protein=ORF7a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27610	27610	.	+	.	ID=ID_220;Name=H73Y;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF7a;aa_name=p.H73Y;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C217T;ps_exc=;chrom_region=ORF7a;protein=ORF7a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	complex	27636	27636	.	+	.	ID=ID_221;Name=V82A;ps_filter=;Variant_seq=GGCTTC;mutation_type=MISSENSE;vcf_gene=ORF7a;aa_name=p.V82A;mat_pep_acc=;ro=0;Reference_seq=AGTTTC;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.T245C;ps_exc=;chrom_region=ORF7a;protein=ORF7a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	complex	27636	27636	.	+	.	ID=ID_221;Name=V82A;ps_filter=;Variant_seq=AGCTTT;mutation_type=;vcf_gene=ORF7a;aa_name=p.V82A;mat_pep_acc=;ro=0;Reference_seq=AGTTTC;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.AGT243_245GGC;ps_exc=;chrom_region=ORF7a;protein=ORF7a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27636	27636	.	+	.	ID=ID_222;Name=VS82AL;ps_filter=;Variant_seq=AGCTTC;mutation_type=;vcf_gene=ORF7a;aa_name=p.VS82AL;mat_pep_acc=;ro=0;Reference_seq=AGTTTC;mat_pep_id=;dp=69;mat_pep_desc=;ao=67;nt_name=g.TTTC245_248CTTT;ps_exc=;chrom_region=ORF7a;protein=ORF7a;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.9710144927536232;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27654	27654	.	+	.	ID=ID_223;Name=F87F;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF7a;aa_name=p.F87F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C261T;ps_exc=;chrom_region=ORF7a;protein=ORF7a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	27691	27691	.	+	.	ID=ID_224;Name=F101_L102del;ps_filter=;Variant_seq=ATTATTG;mutation_type=;vcf_gene=ORF7a;aa_name=p.F101_L102del;mat_pep_acc=;ro=68;Reference_seq=ATTTTTCTTATTG;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.301_306delTTTCTT;ps_exc=;chrom_region=ORF7a;protein=ORF7a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27752	27752	.	+	.	ID=ID_225;Name=T120I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF7a;aa_name=p.T120I;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.C359T;ps_exc=;chrom_region=ORF7a;protein=ORF7a;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27874	27874	.	+	.	ID=ID_226;Name=T40I;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF7b;aa_name=p.T40I;mat_pep_acc=;ro=0;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.C119T;ps_exc=;chrom_region=ORF7b;protein=n/a;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	complex	27906	27906	.	+	.	ID=ID_227;Name=L7fs;ps_filter=;Variant_seq=GTTTTTTTTA;mutation_type=;vcf_gene=ORF8;aa_name=p.L7fs;mat_pep_acc=;ro=66;Reference_seq=GTTTTCTTA;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C18TT;ps_exc=;chrom_region=ORF8;protein=ORF8;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	complex	27906	27906	.	+	.	ID=ID_227;Name=L7fs;ps_filter=;Variant_seq=GTTTTTTTTTTTTA;mutation_type=;vcf_gene=ORF8;aa_name=p.L7fs;mat_pep_acc=;ro=66;Reference_seq=GTTTTCTTA;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C18TTTTTT;ps_exc=;chrom_region=ORF8;protein=ORF8;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	27906	27906	.	+	.	ID=ID_228;Name=F6F;ps_filter=;Variant_seq=GTTTTTTTA;mutation_type=SILENT;vcf_gene=ORF8;aa_name=p.F6F;mat_pep_acc=;ro=66;Reference_seq=GTTTTCTTA;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C18T;ps_exc=;chrom_region=ORF8;protein=ORF8;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28202	28202	.	+	.	ID=ID_229;Name=S103S;ps_filter=;Variant_seq=A;mutation_type=SILENT;vcf_gene=ORF8;aa_name=p.S103S;mat_pep_acc=;ro=67;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.G309A;ps_exc=;chrom_region=ORF8;protein=ORF8;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	del	28270	28270	.	+	.	ID=ID_230;Name=M1fs;ps_filter=;Variant_seq=TAAATG;mutation_type=;vcf_gene=N;aa_name=p.M1fs;mat_pep_acc=;ro=0;Reference_seq=TAAAATG;mat_pep_id=(N|GU280_gp10|1|1.00);dp=61;mat_pep_desc=;ao=61;nt_name=g.1delA;ps_exc=;chrom_region=intergenic;protein=n/a;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28299	28299	.	+	.	ID=ID_231;Name=Q9L;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=N;aa_name=p.Q9L;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.A26T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28461	28461	.	+	.	ID=ID_232;Name=D63G;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=N;aa_name=p.D63G;mat_pep_acc=;ro=0;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.A188G;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28519	28519	.	+	.	ID=ID_233;Name=D82D;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=N;aa_name=p.D82D;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C246T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28582	28582	.	+	.	ID=ID_234;Name=D103D;ps_filter=;Variant_seq=C;mutation_type=SILENT;vcf_gene=N;aa_name=p.D103D;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.T309C;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28603	28603	.	+	.	ID=ID_235;Name=F110F;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=N;aa_name=p.F110F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C330T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28702	28702	.	+	.	ID=ID_236;Name=K143K;ps_filter=;Variant_seq=G;mutation_type=SILENT;vcf_gene=N;aa_name=p.K143K;mat_pep_acc=;ro=67;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=2;nt_name=g.A429G;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.028985507246376812;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28703	28703	.	+	.	ID=ID_237;Name=D144H;ps_filter=;Variant_seq=C;mutation_type=MISSENSE;vcf_gene=N;aa_name=p.D144H;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G430C;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28748	28748	.	+	.	ID=ID_238;Name=L159L;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=N;aa_name=p.L159L;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=3;nt_name=g.C475T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28786	28786	.	+	.	ID=ID_239;Name=F171F;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=N;aa_name=p.F171F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C513T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28881	28881	.	+	.	ID=ID_240;Name=R203M;ps_filter=caution;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=N;aa_name=p.R203M;mat_pep_acc=;ro=0;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.G608T;ps_exc=neighbour_linked;chrom_region=N;protein=N;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=RNA binding;source=https://www.biorxiv.org/content/10.1101/2021.08.05.455082v1;citation=Syed et al. (2021);comb_mutation=;function_description=Northern blot analysis of novel mutant virus-like-particles (VLPs) shows most increase in RNA content of any N mutation tested, suggesting that this mutation improves virus particle production (requisite RNA packaging signal binding site in nsp15/16 boundary is included in the VLP).;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	28916	28916	.	+	.	ID=ID_241;Name=G215C;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=N;aa_name=p.G215C;mat_pep_acc=;ro=0;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.G643T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29025	29025	.	+	.	ID=ID_242;Name=A251V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=N;aa_name=p.A251V;mat_pep_acc=;ro=66;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=3;nt_name=g.C752T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29074	29074	.	+	.	ID=ID_243;Name=A267A;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=N;aa_name=p.A267A;mat_pep_acc=;ro=66;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=3;nt_name=g.A801T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29095	29095	.	+	.	ID=ID_244;Name=F274F;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=N;aa_name=p.F274F;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C822T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29296	29296	.	+	.	ID=ID_245;Name=D341D;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=N;aa_name=p.D341D;mat_pep_acc=;ro=65;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.C1023T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29392	29392	.	+	.	ID=ID_246;Name=K373N;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=N;aa_name=p.K373N;mat_pep_acc=;ro=65;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=4;nt_name=g.G1119T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.057971014492753624;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29397	29397	.	+	.	ID=ID_247;Name=K375R;ps_filter=;Variant_seq=G;mutation_type=MISSENSE;vcf_gene=N;aa_name=p.K375R;mat_pep_acc=;ro=68;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.A1124G;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29402	29402	.	+	.	ID=ID_248;Name=D377Y;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=N;aa_name=p.D377Y;mat_pep_acc=;ro=0;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.G1129T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29465	29465	.	+	.	ID=ID_249;Name=A398S;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=N;aa_name=p.A398S;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G1192T;ps_exc=;chrom_region=N;protein=N;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29534	29534	.	+	.	ID=ID_250;Name=g.A-24G;ps_filter=;Variant_seq=G;mutation_type=;vcf_gene=ORF10;aa_name=;mat_pep_acc=;ro=66;Reference_seq=A;mat_pep_id=;dp=69;mat_pep_desc=;ao=3;nt_name=g.A-24G;ps_exc=;chrom_region=intergenic;protein=n/a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.043478260869565216;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29579	29579	.	+	.	ID=ID_251;Name=A8S;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF10;aa_name=p.A8S;mat_pep_acc=;ro=68;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.G22T;ps_exc=;chrom_region=ORF10;protein=ORF10;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29580	29580	.	+	.	ID=ID_252;Name=A8V;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF10;aa_name=p.A8V;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C23T;ps_exc=;chrom_region=ORF10;protein=ORF10;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29614	29614	.	+	.	ID=ID_253;Name=C19C;ps_filter=;Variant_seq=T;mutation_type=SILENT;vcf_gene=ORF10;aa_name=p.C19C;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C57T;ps_exc=;chrom_region=ORF10;protein=ORF10;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29627	29627	.	+	.	ID=ID_254;Name=R24C;ps_filter=;Variant_seq=T;mutation_type=MISSENSE;vcf_gene=ORF10;aa_name=p.R24C;mat_pep_acc=;ro=68;Reference_seq=C;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.C70T;ps_exc=;chrom_region=ORF10;protein=ORF10;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29678	29678	.	+	.	ID=ID_255;Name=g.T29678C;ps_filter=;Variant_seq=C;mutation_type=;vcf_gene=intergenic;aa_name=;mat_pep_acc=;ro=68;Reference_seq=T;mat_pep_id=;dp=69;mat_pep_desc=;ao=1;nt_name=g.T29678C;ps_exc=;chrom_region=intergenic;protein=n/a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.014492753623188406;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29742	29742	.	+	.	ID=ID_256;Name=g.G29742T;ps_filter=;Variant_seq=T;mutation_type=;vcf_gene=intergenic;aa_name=;mat_pep_acc=;ro=0;Reference_seq=G;mat_pep_id=;dp=69;mat_pep_desc=;ao=69;nt_name=g.G29742T;ps_exc=;chrom_region=intergenic;protein=n/a;sample_size=69;clade_defining=True;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=1.0;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
NC_045512.2	.	snp	29777	29777	.	+	.	ID=ID_257;Name=g.G29777T;ps_filter=;Variant_seq=T;mutation_type=;vcf_gene=intergenic;aa_name=;mat_pep_acc=;ro=40;Reference_seq=G;mat_pep_id=;dp=41;mat_pep_desc=;ao=1;nt_name=g.G29777T;ps_exc=;chrom_region=intergenic;protein=n/a;sample_size=69;clade_defining=False;viral_lineage=AY.108;multi_aa_name=;multiaa_comb_mutation=;alternate_frequency=0.024390243902439025;function_category=;source=;citation=;comb_mutation=;function_description=;heterozygosity=False;variant=Delta;variant_type=VOC;voi_designation_date=04-Apr-2021;voc_designation_date=11-May-2021;vum_designation_date=;status=de_escalated;
